Processing 00000000.tx.1: Selective Reconstitution and Recovery of Functional -Secretase Complex on Budded Baculovirus Particles* Ikuo Hayashi, Yasuomi Urano, Rie Fukuda, Noriko Isoo, Tatsuhiko Kodama, Takao Hamakubo, Taisuke Tomita, and Takeshi Iwatsubo From the Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo 113-0033, Japan, and the Departments of Molecular Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan Received for publication, May 19, 2004 , and in revised form, June 22, 2004.  

Phrase: "Selective Reconstitution"

Phrase: "and"

Phrase: "Recovery of Functional -Secretase Complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0599766:functional recovery [Sign or Symptom]
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]

Phrase: "on Budded Baculovirus Particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "* Ikuo Hayashi,"

Phrase: "Yasuomi Urano,"

Phrase: "Rie Fukuda,"

Phrase: "Noriko Isoo,"

Phrase: "Tatsuhiko Kodama,"

Phrase: "Takao Hamakubo,"

Phrase: "Taisuke Tomita,"

Phrase: "and"

Phrase: "Takeshi Iwatsubo From the Department of Neuropathology"

Phrase: "and"

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "the Departments of Molecular Biology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Research Center for Advanced Science"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683939:research center [Manufactured Object,Organization]
   760   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo 153-8904,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "May 19,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "June 22,"

Phrase: "2004."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In vitro reconstitution of functions of membrane proteins is often hampered by aggregation, misfolding, or lack of post-translational modifications of the proteins attributable to overexpression. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "In vitro reconstitution of functions of membrane proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0920581:membrane reconstitution [Research Device]
   750   C0597302:protein reconstitution [Molecular Function]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "hampered by aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "misfolding"

Phrase: ","

Phrase: "or"

Phrase: "lack of post-translational modifications of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "attributable to overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596130:Attributable [Mental Process]
Processing 00000000.tx.3: To overcome this technical obstacle, we have developed a method to express multimeric integral membrane proteins in extracellular (budded) baculovirus particles that are released from Sf9 cells co-infected with multiple transmembrane proteins. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "this technical obstacle,"

Phrase: "we"

Phrase: "have"

Phrase: "developed"

Phrase: "a method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "express"

Phrase: "multimeric integral membrane proteins in extracellular"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443238:Integral [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "(budded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2700462:Bud [Plant]
   966   C2945744:bud [Anatomical Structure]

Phrase: ")"

Phrase: "baculovirus particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597177:particles [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "are"

Phrase: "released from Sf9 cells"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C3494245:Sf9 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "co-infected with multiple transmembrane proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439663:Infected [Functional Concept]
Processing 00000000.tx.4: We applied this method to the reconstitution of -secretase, a membrane protease complex that catalyzes the intramembrane cleavage of -amyloid precursor protein to release A peptides, the major component of amyloid deposits in Alzheimer brains as well as of Notch. 

Phrase: "We"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "this method to the reconstitution of -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "a membrane protease complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the intramembrane cleavage of -amyloid precursor protein to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "A peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "the major component of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "deposits in Alzheimer brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0333562:Deposit [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "as well as of Notch."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C1235660:Notch [Body Space or Junction]
   760   C3146287:Well [Manufactured Object]
Processing 00000000.tx.5: When we co-infected Sf9 cells with human presenilin 1 (PS1), nicastrin, APH-1a, and PEN-2, a high-molecular-weight membrane protein complex that contained PS1 exclusively in its fragment form associated with three other cofactor proteins was reconstituted and recovered in a highly -secretase-active state in budded virus particles, whereas nonfunctional PS1 holoproteins massively contaminated the parental Sf9 cell membranes. 

Phrase: "When"

Phrase: "we co-infected Sf9 cells with human presenilin 1 (PS1),"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C3494245:Sf9 Cells [Cell]
   762   C0427861:Human cells [Laboratory or Test Result]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "nicastrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "PEN-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "a high-molecular-weight membrane protein complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1523872:protein complex [Cell Component]
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that contained PS1 exclusively in its fragment form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "associated with three"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205449:Three [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "other cofactor proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "reconstituted"

Phrase: "and"

Phrase: "recovered in a highly -secretase-active state"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0679217:active state [Finding]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Active [Functional Concept]
   748   C0205250:Highly [Qualitative Concept]
   748   C0521108:recovered [Qualitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]
   714 E C2004454:recover [Organism Function]

Phrase: "in budded virus particles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "whereas"

Phrase: "nonfunctional PS1 holoproteins massively"

Phrase: "contaminated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205279:Contaminated [Functional Concept]
  1000   C2349974:CONTAMINATED [Idea or Concept]

Phrase: "the parental Sf9 cell membranes."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0007603:Cell membranes [Cell Component]
   861   C3494245:Sf9 Cell [Cell]
   827 E C3161472:Cell Membrane [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0025255:Membranes [Tissue]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.6: The relative -secretase activity (per molar PS1 fragments) was concentrated by 2.5 fold in budded virus particles compared with that in Sf9 membranes. 

Phrase: "The relative -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "per molar PS1 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "concentrated by 2.5 fold"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0332462:Fold [Spatial Concept]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   760   C1880834:FOLD [Phenomenon or Process]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "in budded virus particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in Sf9 membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.7: The budded baculovirus system will facilitate structural and functional analyses of -secretase, as well as screening of its binding molecules or inhibitors, and will also provide a versatile methodology for the characterization of a variety of membrane protein complexes.  

Phrase: "The budded baculovirus system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "will"

Phrase: "facilitate"

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional analyses of -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "screening of its binding molecules"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "or"

Phrase: "inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "will"

Phrase: "also"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a versatile methodology for the characterization of a variety of membrane protein complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0969625:methodology [Intellectual Product]
   735   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.8: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  A wide variety of protein expression systems using heterologous organisms have been applied to the structural and functional analyses of multispan membrane proteins. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A wide variety of protein expression systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "heterologous organisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029235:Organisms [Organism]

Phrase: "have"

Phrase: "been"

Phrase: "applied to the structural"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0678594:Structural [Spatial Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "functional analyses of multispan membrane proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0558024:Functional analysis [Health Care Activity]
   750   C1514534:Protein Analysis [Molecular Biology Research Technique]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
Processing 00000000.tx.9: However, overexpression and recovery of membrane proteins in a biologically active state are often hampered by the following problems. 

Phrase: "However,"

Phrase: "overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "recovery of membrane proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237820:Recovery [Activity]
   770   C1555688:recovery [Idea or Concept]
   770   C2004454:Recovery [Organism Function]

Phrase: "in a biologically active state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0679217:active state [Finding]
   827   C0205177:Active [Functional Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "are"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "hampered by the following problems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1546466:Problems [Idea or Concept]
   726 E C0033213:Problem [Finding]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.10: First, a significant proportion of overexpressed proteins tend to misfold and aggregate without forming proper tertiary structures. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a significant proportion of overexpressed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "tend to misfold"

Phrase: "and"

Phrase: "aggregate without forming proper tertiary structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.11: Second, lack of appropriate post-translational modifications, interaction with binding-partner proteins, or proper intracellular transport render the membrane proteins stuck within the early compartments of intracellular membrane trafficking. 

Phrase: "Second, lack of appropriate post-translational modifications,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "interaction with binding-partner proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0872079:interaction protein [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "proper intracellular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599814:Intracellular Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "render"

Phrase: "the membrane proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025255:Membrane [Tissue]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "stuck within the early compartments of intracellular membrane"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0021868:Intracellular membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0175996:intracellular [Cell Component]
   744   C0178719:Intracellular [Spatial Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1185625:Compartments [Body Space or Junction]
   744   C1279919:Early [Temporal Concept]
   744   C1382196:Compartments [Natural Phenomenon or Process]
   744   C1706182:Membrane [Manufactured Object]
   711   C1706582:Stick [Biomedical or Dental Material]
   711   C1706583:Stick [Quantitative Concept]
   711 E C2986730:Compartment [Spatial Concept]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.12: Furthermore, serious contamination of biologically inactive, nascent, or misfolded proteins is inevitable, which makes the analysis of the functional form of protein difficult. 

Phrase: "Furthermore,"

Phrase: "serious contamination of biologically inactive, nascent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0259846:contamination [Human-caused Phenomenon or Process]
   753   C1881659:CONTAMINATION [Event]
   753   C2349974:Contamination [Idea or Concept]

Phrase: "or"

Phrase: "misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "inevitable,"

Phrase: "which"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the analysis of the functional form of protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0558024:Functional analysis [Health Care Activity]
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.13: The infection of recombinant baculovirus into Spodoptera frugiperda insect cells (Sf9) is one of the most widely used methodologies that achieves a high level of expression and yield of recombinant membrane proteins (1). 

Phrase: "The infection of recombinant baculovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "into Spodoptera frugiperda insect cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Sf9"

Phrase: ")"

Phrase: "is"

Phrase: "one of the most widely used methodologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "achieves"

Phrase: "a high level of expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C3244092:expression level [Idea or Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "yield of recombinant membrane proteins"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Baculovirus produces budded virus (BV),1 i.e. particles that contain viral DNA enveloped within Sf9 cell-derived membranes, during its life cycle (Fig. 1). 

Phrase: "Baculovirus"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079005:Baculovirus [Virus]
  1000   C0935640:Baculovirus [Virus]
   944 E C0376406:Granulosis Virus [Virus]

Phrase: "produces"

Phrase: "budded virus (BV),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "1 i.e. particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597177:particles [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "viral DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012939:DNA, Viral [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521026:Viral [Functional Concept]

Phrase: "enveloped within Sf9 cell-derived membranes,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C3494245:Sf9 Cell [Cell]
   783   C0007603:Cell membranes [Cell Component]
   767 E C3161472:Cell Membrane [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0025255:Membranes [Tissue]
   753   C1269647:Cell [Cell]
   753   C1441547:Derived [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3245521:derived [Idea or Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "during its life cycle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023675:Life Cycle [Temporal Concept]
   861   C0376558:Life [Idea or Concept]
   861   C1511572:Cycle [Temporal Concept]
   777 E C0595998:lives [Finding]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.15: Recently, it has been reported that a seventh membrane-spanning, G protein-coupled receptor was successfully recovered in BV in a functional form complexed with heterotrimeric G proteins and adenylyl cyclase (2, 3). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a seventh membrane-spanning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1711300:Span [Conceptual Entity]
   793   C2700613:Span [Quantitative Concept]

Phrase: "G protein-coupled receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "was"

Phrase: "successfully"

Phrase: "recovered in BV"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   770   C0521108:recovered [Qualitative Concept]
   737 E C2004454:recover [Organism Function]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "in a functional form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "complexed with heterotrimeric G proteins"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C0752348:Heterotrimeric G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   845 E C1325335:heterotrimeric G-protein [Cell Component]
   806   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   781 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   764   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1523872:protein complex [Cell Component]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439267:g% [Quantitative Concept]
   726   C0439855:Complex [Qualitative Concept]
   726   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "adenylyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Using this strategy, sterol regulatory element-binding protein-2 (SREBP) and SREBP cleavage-activating protein, which are endoplasmic reticulum-resident membrane proteins in mammalian cells, also were displayed on BV particles with a lesser extent of aggregation and degradation compared with those in cellular membrane fractions (4). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this strategy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "sterol regulatory element-binding protein-2 (SREBP)"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   858   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C2246292:sterol binding [Molecular Function]
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0038323:Sterol [Steroid]
   799   C0220905:regulatory [Regulation or Law]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704735:Regulatory [Conceptual Entity]
   799   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "SREBP cleavage-activating protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   733   C1327378:sterol regulatory element binding protein cleavage [Molecular Function]

Phrase: "which"

Phrase: "are"

Phrase: "endoplasmic reticulum-resident membrane proteins in mammalian cells,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   793   C0230770:Endoplasmic reticulum, membrane [Cell Component]
   776   C0242391:Cell Membrane Proteins [Amino Acid, Peptide, or Protein,Receptor]
   770   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0007603:cells membrane [Cell Component]
   760 E C1179841:Cell membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750 E C3161472:Cell Membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]

Phrase: "also"

Phrase: "were"

Phrase: "displayed on BV particles"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0042760:Virus Particles [Cell Component]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C0597177:particles [Chemical Viewed Structurally]
   760   C0870432:displayed [Functional Concept]
   726 E C1705417:Display [Manufactured Object]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]

Phrase: "with a lesser extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "of aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "compared with those in cellular membrane fractions"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0007603:Cellular membrane [Cell Component]
   778   C3161472:Cellular Membrane [Cell Component]
   748   C0007634:Cellular [Cell]
   748   C0025255:Membrane [Tissue]
   748   C0178539:Cellular [Functional Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1264633:Fractions [Quantitative Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C1707455:Compared [Activity]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.17: However, selective reconstitution of a protein complex composed of multiple integral membrane proteins in a biologically active state has not been achieved yet. 

Phrase: "However,"

Phrase: "selective reconstitution of a protein complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0597302:protein reconstitution [Molecular Function]

Phrase: "composed of multiple integral membrane proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0443238:Integral [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "in a biologically active state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0679217:active state [Finding]
   827   C0205177:Active [Functional Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "achieved"

Phrase: "yet."
Processing 00000000.tx.18: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.19: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.20: Life cycle of baculovirus and generation of BV. 

Phrase: "Life cycle of baculovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0023675:Life Cycle [Temporal Concept]
   770   C0376558:Life [Idea or Concept]
   770   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "generation of BV."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]
Processing 00000000.tx.21: Baculovirus undergoes a biphasic life cycle in its lepidopteron host. 

Phrase: "Baculovirus"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079005:Baculovirus [Virus]
  1000   C0935640:Baculovirus [Virus]
   944 E C0376406:Granulosis Virus [Virus]

Phrase: "undergoes"

Phrase: "a biphasic life cycle in its lepidopteron host."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023675:Life Cycle [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.22: Intracellular copies of viral DNA are targeted into BV or alternatively incorporated within occlusion-derived virus (ODV) within the nucleus.  

Phrase: "Intracellular copies of viral DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0006556:copies dna [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1948062:Copies [Manufactured Object]

Phrase: "are"

Phrase: "targeted into BV"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   770   C1521840:Targeted [Functional Concept]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "alternatively"

Phrase: "incorporated within occlusion-derived virus (ODV)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0011382:Occlusion [Organ or Tissue Function]
   760   C0028778:Occlusion [Pathologic Function]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C0441597:Occlusion [Functional Concept]
   760   C1110554:OCCLUSION [Pathologic Function]
   760   C1441547:Derived [Qualitative Concept]
   760   C1882137:OCCLUSION [Phenomenon or Process]
   760   C1947917:Occlusion, NOS [Functional Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "within the nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.23: -Secretase is a membrane-bound protease complex composed of at least four transmembrane proteins, i.e. presenilin (PS), which is predicted to harbor the catalytic center as an aspartic protease, as well as nicastrin (NCT), APH-1, and PEN-2 as essential transmembrane cofactor proteins (5, 6). 

Phrase: "-Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a membrane-bound protease complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "composed of"

Phrase: "at least four transmembrane proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1167322:transmembrane [Cell Component]
   812   C2752508:transmembrane [Cell Component]

Phrase: "i.e. presenilin (PS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "the catalytic center as an aspartic protease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "as well as"

Phrase: "nicastrin (NCT),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "PEN-2 as essential transmembrane cofactor proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   789   C1420777:TRANSMEMBRANE PROTEIN 2 [Gene or Genome]
   778   C3541303:PEN-2 [Gene or Genome]
   757   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178555:Cofactor [Biologically Active Substance]
   748   C0205224:Essential [Qualitative Concept]
   748   C1167322:transmembrane [Cell Component]
   748   C2752508:transmembrane [Cell Component]
   748   C3273588:Pen [Manufactured Object]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.24: -Secretase is responsible for the intramembrane cleavage of a subset of type 1, single-span membrane proteins (7), including -amyloid precursor protein (APP), to form amyloid peptides (A); 

Phrase: "-Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "responsible for the intramembrane cleavage of a subset of type 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]

Phrase: "single-span membrane proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.25: A is the major component of amyloid deposits in the brains of patients with Alzheimer's disease and is closely linked to the pathogenesis of Alzheimer's disease (8). 

Phrase: "A"

Phrase: "is"

Phrase: "the major component of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "deposits in the brains of patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0333562:Deposit [Functional Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "closely"

Phrase: "linked to the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.26: Another important substrate of -secretase is Notch, the intracellular domain (ICD) of which is released by -secretase and enters the nucleus, thereby transducing intercellular information during tissue development and renewal through transactivation of gene expression (8). 

Phrase: "Another important substrate of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "Notch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "the intracellular domain (ICD) of which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "released by -secretase"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "thereby"

Phrase: "transducing"

Phrase: "intercellular information during tissue development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "renewal through transactivation of gene expression"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.27: Overexpression of the four putative -secretase components in mammalian or Drosophila cells led to the maturation of -secretase protein complex, i.e. endoproteolysis of PS to generate fragments (the amino-terminal fragment and the carboxyl-terminal fragment, respectively) and high-molecular-weight (HMW) complex formation, as well as an up-regulation of the proteolytic activity (9-12). 

Phrase: "Overexpression of the four putative -secretase components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "in mammalian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammalian [Mammal]

Phrase: "or"

Phrase: "Drosophila cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "led to the maturation of -secretase protein complex,"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   770   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1523872:protein complex [Cell Component]
   767   C1660003:protein maturation [Cell Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0439855:Complex [Qualitative Concept]
   744   C0678723:Maturation [Organism Function]
   744   C0870861:maturation [Phenomenon or Process]
   744   C1254042:Maturation [Physiologic Function]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1708698:LED [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "i.e. endoproteolysis of PS to"

Phrase: "generate"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "the amino-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "the carboxyl-terminal fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "high-molecular-weight (HMW) complex formation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]
   717   C1979900:High molecular weight [Qualitative Concept]

Phrase: "as well as"

Phrase: "an up-regulation of the proteolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1514825:Regulation of Proteolysis [Molecular Function]
           Proteolytic Regulation
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(9-12"

Phrase: ")."
Processing 00000000.tx.28: Importantly, overexpression of all four components in Saccharomyces cerevisiae, which lacks endogenous -secretase activity, successfully reconstituted the -secretase activity (13), strongly suggesting that a membrane protein complex composed of these four proteins represents the minimal framework of -secretase. 

Phrase: "Importantly,"

Phrase: "overexpression of all four components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in Saccharomyces cerevisiae,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036025:Saccharomyces cerevisae [Fungus]
   861   C0036024:Saccharomyces [Fungus]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "endogenous -secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "successfully"

Phrase: "reconstituted"

Phrase: "the -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a membrane protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "composed of these four proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205450:Four [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the minimal framework of -secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.29: Selective recovery and purification of the active form of -secretase complex is essential to its functional and structural characterization, although a majority of exogenously overexpressed PS polypeptides remain inactive in the low-molecular-weight complex that chiefly contains PS holoprotein, presumably because of lack of binding with other essential cofactor proteins (14). 

Phrase: "Selective recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237820:Recovery [Activity]
   861   C1555688:recovery [Idea or Concept]
   861   C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "purification of the active form of -secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "is"

Phrase: "essential to its functional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "structural characterization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "although"

Phrase: "a majority of exogenously overexpressed PS polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "remain"

Phrase: "inactive in the low-molecular-weight complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205254:Inactive [Qualitative Concept]

Phrase: "that chiefly"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "PS holoprotein,"

Phrase: "presumably because of lack of binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0243122:binding [Functional Concept]
   753   C0332268:lack [Qualitative Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "with other essential cofactor proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.30: Here, we applied the baculovirus BV particle technology to the reconstitution of -secretase and succeeded in the selective recovery of the active form of -secretase, composed of fragment forms of PS1 complexed with NCT, APH-1a, and PEN-2.  

Phrase: "Here,"

Phrase: "we"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "the baculovirus BV particle technology to the reconstitution of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0039421:Technology [Occupation or Discipline]

Phrase: "and"

Phrase: "succeeded in the selective recovery of the active form of -secretase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   738   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205177:Active [Functional Concept]
   738   C0237820:Recovery [Activity]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1522492:Form [Functional Concept]
   738   C1555688:recovery [Idea or Concept]
   738   C2004454:Recovery [Organism Function]

Phrase: "composed of fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332255:fragment [Functional Concept]
   790   C1708096:Fragment [Qualitative Concept]

Phrase: "forms of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1522492:Form [Functional Concept]

Phrase: "complexed with NCT,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1538050:NICASTRIN [Gene or Genome]
   756   C0439855:Complex [Qualitative Concept]
   756   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "PEN-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]
Processing 00000000.tx.31: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Construction of Expression Plasmid and BV Particle PreparationFull-length cDNAs encoding PS1 in pcDNA3 vector (Invitrogen) (15) and NCT fused with V5/His tags in pEF6-V5/His vector (Invitrogen) (16) were amplified by polymerase chain reaction and inserted into pBlueBac4.5 (Invitrogen). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Construction of Expression Plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "BV Particle PreparationFull-length cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "PS1 in pcDNA3 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "NCT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "fused with V5/"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0699952:Fused [Functional Concept]
   790   C2349105:V5+ [Element, Ion, or Isotope]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "His tags in pEF6-V5/"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1139855:tags [Medical Device]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "His vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "(16"

Phrase: ")"

Phrase: "were"

Phrase: "amplified by polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "inserted into pBlueBac4.5"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0441587:Inserted [Health Care Activity]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.32: A cDNA encoding human APH-1a was sub-cloned into a pEF4-myc/His A vector (Invitrogen) from a brain cDNA library (Clontech) and subsequently inserted into pBlueBac4.5. 

Phrase: "A cDNA encoding human APH-1a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1538913:APH-1A [Gene or Genome]
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "was"

Phrase: "sub-cloned into a pEF4-myc/"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0009013:cloned [Cell]
   753   C0542339:Sub- [Spatial Concept]
   753   C1264637:SUB [Quantitative Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "His A vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "from a brain cDNA library"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0023621:Library [Manufactured Object,Organization]
   827   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "and"

Phrase: "subsequently"

Phrase: "inserted into pBlueBac4.5."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0441587:Inserted [Health Care Activity]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.33: Human PEN-2 cDNA (12) was amplified from a brain cDNA library and inserted into pBlueBacHis2A (Invitrogen) in-frame with an amino-terminal His tag. 

Phrase: "Human PEN-2 cDNA (12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C3541303:PEN-2 [Gene or Genome]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086418:Human [Human]
   804   C3273588:Pen [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "amplified from a brain cDNA library"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0023621:Library [Manufactured Object,Organization]
   753   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "inserted into pBlueBacHis2A"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0441587:Inserted [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "in-frame with an amino-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080089:Frame [Nucleotide Sequence]
   753   C0180979:Frame [Medical Device]
   753   C1705858:Frame [Manufactured Object]

Phrase: "His tag."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037293:Tag [Neoplastic Process]
  1000   C0181496:Tag [Manufactured Object]
  1000   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.34: D257A and D385A mutations of PS1 were inserted by the long-polymerase chain reaction method (15). 

Phrase: "D257A"

Phrase: "and"

Phrase: "D385A mutations of PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "inserted by the long-polymerase chain reaction method"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0025663:Method [Intellectual Product]
   744   C0205166:Long [Qualitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0441587:Inserted [Health Care Activity]
   744   C0443286:Reaction [Functional Concept]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524075:Chain [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   711 E C1743766:Insert [Medical Device]
   711 E C1883719:Insert [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.35: Recombinant baculovirus construction, culture of Sf9 cells, and the isolation of baculovirus BV were performed as described previously (3, 4). 

Phrase: "Recombinant baculovirus construction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "culture of Sf9 cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0007585:cells culture [Laboratory Procedure]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "the isolation of baculovirus BV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.36: The recombinant viruses were generated from Sf9 cells co-transfected with the vector for human PS1, NCT, APH-1a, or PEN-2 and Bac-N-Blue viral DNA (Invitrogen) by homologous recombination and sequential plaque-purification/amplification. 

Phrase: "The recombinant viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0597363:recombinant virus [Virus]
   861   C0042776:Viruses [Virus]
   861   C0521026:viruses [Functional Concept]
   827 E C0319157:virus [Virus]

Phrase: "were"

Phrase: "generated from Sf9 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C3494245:Sf9 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3146294:Generated [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with the vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "for human PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "or"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "and"

Phrase: "Bac-N-Blue viral DNA (Invitrogen"

Phrase: ")"

Phrase: "by homologous recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599773:Homologous Recombination [Genetic Function]
  1000   C2984295:Homologous recombination [Functional Concept]
   861   C0034865:Recombination [Genetic Function]
   861   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "sequential plaque-purification/amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.37: Sf9 cells were cultured in Grace's supplemented media (Invitrogen) containing 10% fetal bovine serum, 0.1% Pluronic F-68 (Invitrogen), 100 international units/ml of penicillin, and 100 g/ml of streptomycin (Invitrogen) in a 1-liter spinner flask at 27 C. 

Phrase: "Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Grace's supplemented media"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   813   C0492553:SUPPLEMENT, CULTURE MEDIA [Medical Device]
   781   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0242295:Supplement [Food]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726   C1947943:Supplement [Intellectual Product]
   726   C2242979:Culture [Laboratory Procedure]
   726   C2348609:Supplement [Functional Concept]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "0.1% Pluronic F-68"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0032254:Pluronic F-68 [Organic Chemical]
   804   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   804   C0032251:pluronic [Organic Chemical]
   804   C0439133:(f) [Intellectual Product]
   804   C0450387:68 [Intellectual Product]
   804   C1553038:[f] [Quantitative Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "100 international units/ml of penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C2945590:unit/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml of streptomycin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1300565:g/mL [Quantitative Concept]
   797 E C1637390:mL/g [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "in a 1-liter spinner flask"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0402790:Spinner [Professional or Occupational Group]
   804   C0872171:Flask [Medical Device]

Phrase: "at 27 C."
Processing 00000000.tx.38: Sf9 cells (2 x 106 cells/ml) were co-infected with a combination of recombinant baculoviruses at a multiplicity of infection of 2 for each virus and harvested 72 h after infection. 

Phrase: "Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(2 x 106 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2699156:Cells/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "co-infected with a combination of recombinant baculoviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439663:Infected [Functional Concept]

Phrase: "at a multiplicity of infection"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0009450:Infection, NOS [Disease or Syndrome]
   827   C0449822:Multiplicity [Quantitative Concept]
   755 E C0439064:Multiple [Quantitative Concept]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "of 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "for each virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042776:Virus [Virus]
  1000   C0319157:virus [Virus]

Phrase: "and"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "72 h after infection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.39: Fractionation and solubilization of Sf9 membranes in 1% CHAPSO containing HEPES buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, and Complete protease inhibitor mixture (Roche Applied Sciences)) were performed as described previously (12, 17). 

Phrase: "Fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "solubilization of Sf9 membranes"

Phrase: "in 1% CHAPSO containing HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "Complete protease inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "(Roche Applied Sciences"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C0681834:Applied Science [Research Activity]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: ")"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.40: To isolate the virus particles, the culture medium was centrifuged at 1,000 x g for 15 min to precipitate cells, and the supernatant was further centrifuged at 40,000 x g for 30 min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "the virus particles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042760:Virus Particles [Cell Component]
   861   C0597177:particles [Chemical Viewed Structurally]

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000 x g for 15 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "centrifuged at 40,000 x g"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1955160:40 g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.41: The pellets were resuspended and centrifuged again at 1,000 x g for 15 min and 40,000 x g for 30 min to eliminate possible contamination of cell debris. 

Phrase: "The pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended"

Phrase: "and"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "again at 1,"

Phrase: "000 x g for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0560021:g/min [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "40,000 x g for 30 min to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0560021:g/min [Quantitative Concept]
   767   C1955160:40 g [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]

Phrase: "eliminate"

Phrase: "possible contamination of cell debris."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0259846:contamination [Human-caused Phenomenon or Process]
   760   C1881659:CONTAMINATION [Event]
   760   C2349974:Contamination [Idea or Concept]
Processing 00000000.tx.42: All procedures were carried out at 4 C. 

Phrase: "All procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 4 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.43: The precipitates were resuspended in phosphate-buffered saline or assay buffer and stored at 4 C until used as BV fractions. 

Phrase: "The precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "resuspended in phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "stored at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "used as BV fractions."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.44: BV fractions were solubilized by 1% CHAPSO containing HEPES buffer and centrifuged. 

Phrase: "BV fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "solubilized by 1% CHAPSO containing HEPES buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0055270:chapso [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332256:Containing [Functional Concept]
   748   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "centrifuged."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]
Processing 00000000.tx.45: Supernatants were used as enzyme sources in in vitro reaction. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used as enzyme sources"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0449416:sources [Finding]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1705919:Source [Idea or Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in in vitro reaction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.46: In Vitro -Secretase AssayIn vitro -secretase assay was performed as described previously with some modifications (12, 17). 

Phrase: "In Vitro -Secretase AssayIn vitro -secretase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   900   C1515653:In Vitro Assay [Research Activity]
   795   C0005507:Assay [Laboratory Procedure]
   795   C0243073:assay [Qualitative Concept]
   795   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously with some modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "(12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.47: N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT) was a gift from Drs. 

Phrase: "N-[N-(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: "5-Difluorophenacetyl"

Phrase: ")-"

Phrase: "L-alanyl"

Phrase: "]-"

Phrase: "("

Phrase: "S)-"

Phrase: "phenylglycine t-butyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: "(DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: ")"

Phrase: "was"

Phrase: "a gift from Drs."
Processing 00000000.tx.48: Kan and Fukuyama (University of Tokyo) (18). 

Phrase: "Kan"

Phrase: "and"

Phrase: "Fukuyama"

Phrase: "(University of Tokyo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.49: L-685,458 was purchased from Bachem. 

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from Bachem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.50: Membrane fractions from HeLa cells were isolated and solubilized as described previously (12, 17). 

Phrase: "Membrane fractions from HeLa cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0805525:Cell fractions [Cell Component]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "solubilized"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.51: Purified recombinant substrates (i.e. carboxyl-terminally tagged C100 or N102, respectively) were incubated with the solubilized membrane or BV fraction in modified 1x buffer (HEPES buffer containing 0.25% CHAPSO, 5 mM EDTA, 5 M 1,10-phenanthroline, 10 mg/ml of phosphoramidon, and 0.1% phosphatidylcholine (Avanti)) for 6 h at 37 C. 

Phrase: "Purified recombinant substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "(i.e. carboxyl-terminally tagged C100"

Phrase: "or"

Phrase: "N102,"

Phrase: "respectively"

Phrase: ")"

Phrase: "were"

Phrase: "incubated with the solubilized membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "or"

Phrase: "BV fraction in modified 1x buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1264633:Fraction [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "(HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.25% CHAPSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0055270:chapso [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5 M 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439084:>5 [Quantitative Concept]
   827   C0441923:M+ [Intellectual Product]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "10 mg/ml of phosphoramidon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0439294:mg ml [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "0.1% phosphatidylcholine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   771 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   771 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "(Avanti"

Phrase: ")"

Phrase: ")"

Phrase: "for 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.52: The samples were centrifuged, and the supernatants were analyzed as described previously (12, 17). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: ","

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.53: Antibodies, Fractionation, and Immunochemical AnalysesAnti-G1Nr2 and G1L3 antibodies against glutathione S-transferase-fused human PS1 N terminus or hydrophilic loop, respectively, have been described previously (19, 20). 

Phrase: "Antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Fractionation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Immunochemical AnalysesAnti-G1Nr2"

Phrase: "and"

Phrase: "G1L3 antibodies against glutathione S-transferase-fused human PS1 N terminus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   703 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "hydrophilic loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "respectively,"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.54: Rabbit anti-PEN-2 antibody PNT3 was raised against a synthetic peptide corresponding to the amino-terminal 26 amino acids of human/mouse PEN-2. 

Phrase: "Rabbit anti-PEN-2 antibody PNT3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   709   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "raised against a synthetic peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0442818:Raised [Quantitative Concept]
   760   C1883254:synthetic [Activity]

Phrase: "corresponding to the amino-terminal 26 amino acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   811   C1706793:Amino-Terminal Amino Acid [Amino Acid Sequence]
   767   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750 E C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0205088:Terminal [Temporal Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "of human/mouse PEN-2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C3541303:PEN-2 [Gene or Genome]
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C0086418:Human [Human]
   812   C3273588:Pen [Manufactured Object]
Processing 00000000.tx.55: Other antibodies were purchased from Cell Signaling Technology (anti-myc 9B11, anti-cleaved Notch1 (V1744)), Invitrogen (anti-V5), or Roche Applied Sciences (antimyc 9E10). 

Phrase: "Other antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Cell Signaling Technology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C0869011:purchased [Activity]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "(anti-myc 9B11,"

Phrase: "anti-cleaved Notch1"

Phrase: "(V1744"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "Invitrogen"

Phrase: "(anti-V5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "Roche Applied Sciences"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C0681834:Applied Science [Research Activity]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: "(antimyc 9E10"

Phrase: ")."
Processing 00000000.tx.56: Membrane fractionation, immunoblot analysis, immunoprecipitation, or quantitation of A by two-site ELISAs were performed as described previously (12, 15-17, 19-23). 

Phrase: "Membrane fractionation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "immunoblot analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "or"

Phrase: "quantitation of A by two-site ELISAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "15-17,"

Phrase: "19-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.57: Size Exclusion Chromatography of Solubilized Sf9 Membrane and BV Fractions1% CHAPSO-solubilized Sf9 membranes and BV fractions were diluted 4-fold (final concentration of CHAPSO, 0.25%) and loaded onto a Superose 6 HR 10/30 column (Amersham Biosciences) on an AKTA Explorer chromatography system (Amersham Biosciences). 

Phrase: "Size Exclusion Chromatography of Solubilized Sf9 Membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   814   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0456389:size [Spatial Concept]
   748   C0680251:EXCLUSION [Functional Concept]
   748   C2828389:Exclusion [Activity]

Phrase: "and"

Phrase: "BV Fractions1% CHAPSO-solubilized Sf9 membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   795   C0025255:Membranes [Tissue]
   762 E C0596901:Membrane [Cell Component]
   762 E C1706182:Membrane [Manufactured Object]
   712 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "BV fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(final concentration of CHAPSO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "0.25%"

Phrase: ")"

Phrase: "and"

Phrase: "loaded onto a Superose 6 HR 10/30 column"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   762   C0439187:/10^6 [Quantitative Concept]
   762   C1881839:10^6 [Quantitative Concept]
   742   C1185738:Column [Body Part, Organ, or Organ Component]
   742   C1706132:Column [Idea or Concept]
   742   C1708715:Loaded [Activity]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "on an AKTA Explorer chromatography system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.58: The column was eluted with HEPES buffer containing 0.25% CHAPSO. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "eluted with HEPES buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.25% CHAPSO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0055270:chapso [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.59: Subsequent separation of HMW Native marker kit (Amersham Biosciences) was used as a molecular weight reference. 

Phrase: "Subsequent separation of HMW Native marker kit (Amersham Biosciences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0036679:Separation [Pathologic Function]
   738   C0237868:Separation [Social Behavior]
   738   C1881713:SEPARATION [Phenomenon or Process]

Phrase: ")"

Phrase: "was"

Phrase: "used as a molecular weight reference."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0424662:Reference weight [Finding]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1273517:used [Finding]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1514811:Reference [Idea or Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C1706462:Reference [Conceptual Entity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.60: Each eluate fraction was collected and analyzed by immunoblot analysis.  

Phrase: "Each eluate fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed by immunoblot analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
           Analyzed
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.61: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Selective Recovery of PS1 Fragments and Cofactor Proteins on BVWe infected Sf9 cells with a recombinant baculovirus containing a cDNA encoding human PS1 that harbors the catalytic site of -secretase. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Selective Recovery of PS1 Fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "Cofactor Proteins on BVWe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "Sf9 cells with a recombinant baculovirus"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C3494245:Sf9 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a cDNA encoding human PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1418985:PRESENILIN 1 [Gene or Genome]
   804   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "harbors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "the catalytic site of -secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.62: Previous studies showed that endoproteolysis of PS is associated with the acquisition of -secretase activity in mammalian cells (5-8). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that endoproteolysis of PS"

Phrase: "is"

Phrase: "associated with the acquisition of -secretase activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1706701:Acquisition [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.63: Immunoblot analysis of Sf9 membrane fractions showed a robust expression of PS1 polypeptide chiefly in a holoprotein form (Fig. 2A, left lane), which is known to be -inactive and which was in agreement with previous reports (24, 25). 

Phrase: "Immunoblot analysis of Sf9 membrane fractions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a robust expression of PS1 polypeptide chiefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a holoprotein form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "left lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be -"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "and"

Phrase: "which"

Phrase: "was in agreement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0680240:Agreement [Social Behavior]
   790   C1421478:WAS [Gene or Genome]

Phrase: "with previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.64: View larger version (42K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.65: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.66: Characterization of reconstituted PS1 complex. 

Phrase: "Characterization of reconstituted PS1 complex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]
Processing 00000000.tx.67: A, immunoblot analysis of Sf9 membranes infected with combinations of PS1, NCT-V5/His, APH-1a-myc/His, His-PEN-2, or BV particles. 

Phrase: "A,"

Phrase: "immunoblot analysis of Sf9 membranes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "infected with combinations of PS1,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C0439663:Infected [Functional Concept]
   753   C0453882:Combinations [Manufactured Object]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "NCT-V5/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "His,"

Phrase: "APH-1a-myc/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538913:APH-1A [Gene or Genome]

Phrase: "His,"

Phrase: "His-PEN-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "or"

Phrase: "BV particles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]
Processing 00000000.tx.68: Note that PS1 fragments (arrowheads) were detected in lysates from cells or BV thereof infected with all four components. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that PS1 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "were"

Phrase: "detected in lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C1881488:Lysate [Physical Object]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "BV thereof"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "infected with all four components."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205450:Four [Quantitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.69: B, co-immunoprecipitation (IP) analysis of solubilized BV. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "co-immunoprecipitation (IP) analysis of solubilized BV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.70: Immunoprecipitates with anti-PS1 antibody (G1L3) or preimmune serum (p.i.) were analyzed by Western blotting with antibodies to PS1 or other components. 

Phrase: "Immunoprecipitates with anti-PS1 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(G1L3"

Phrase: ")"

Phrase: "or"

Phrase: "preimmune serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "(p.i."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "other components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.71: C, separation of reconstituted PS1 complex in BV by gel filtration.  

Phrase: "C,"

Phrase: "separation of reconstituted PS1 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "in BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "by gel filtration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]
Processing 00000000.tx.72: We next infected the Sf9 cells with various combinations of recombinant baculoviruses encoding other -secretase components (i.e. NCT, APH-1a, and PEN-2, collectively referred to as cofactors) in addition to PS1. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "the Sf9 cells with various combinations of recombinant baculoviruses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C3494245:Sf9 Cells [Cell]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "other -secretase components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "(i.e. NCT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1538050:NICASTRIN [Gene or Genome]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "PEN-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "collectively"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as cofactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0178555:cofactors [Biologically Active Substance]
   790   C1883351:To [Qualitative Concept]

Phrase: ")"

Phrase: "in addition to PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.73: Immunoblot analysis showed that PS1 underwent endoproteolysis to generate an amino-terminal fragment and a carboxyl-terminal fragment corresponding to the size of mammalian PS1 fragments only when all four components were infected, although a major proportion of recombinant PS1 polypeptide remained as a holoprotein (Fig. 2A, right lane). 

Phrase: "Immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "underwent"

Phrase: "endoproteolysis to"

Phrase: "generate"

Phrase: "an amino-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "a carboxyl-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to the size of mammalian PS1 fragments only"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   739   C0024660:Mammalian [Mammal]
   739   C0205171:Only [Quantitative Concept]
   739   C0332255:fragments [Functional Concept]
   739   C0456389:size [Spatial Concept]
   739   C0486805:Fragments [Body Substance]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1720467:Only [Intellectual Product]
   706 E C1708096:Fragment [Qualitative Concept]

Phrase: "when"

Phrase: "all four components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: ","

Phrase: "although"

Phrase: "a major proportion of recombinant PS1 polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709707:Proportion [Quantitative Concept]

Phrase: "remained as a holoprotein"

Phrase: "(Fig. 2A,"

Phrase: "right lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.74: In contrast, PS1 fragments were hardly generated upon expression of PS1 plus one or two of the cofactor proteins (Fig. 2A and data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "PS1 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "were"

Phrase: "hardly"

Phrase: "generated upon expression of PS1 plus one"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   767   C0442722:one plus [Finding]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205447:One [Quantitative Concept]
   744   C0332287:Plus [Qualitative Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "two of the cofactor proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "(Fig. 2A"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: Co-immunoprecipitation studies revealed that any two of the components among PS1 (holoprotein as well as fragments), NCT, APH-1a, or PEN-2 were coimmunoprecipitated in Sf9 membranes that expressed the four components (data not shown). 

Phrase: "Co-immunoprecipitation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "any two of the components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "among PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(holoprotein"

Phrase: "as well as"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "NCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "or"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "were"

Phrase: "coimmunoprecipitated in Sf9 membranes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025255:Membranes [Tissue]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "that"

Phrase: "expressed"

Phrase: "the four components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: We then analyzed the BV fractions from Sf9 cells infected with combinations of the four components by immunoblotting. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the BV fractions from Sf9 cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0805525:Cell fractions [Cell Component]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "infected with combinations of the four components"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205450:Four [Quantitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C0449432:Components [Manufactured Object]
   748   C0453882:Combinations [Manufactured Object]
   714 E C0205195:Combination [Qualitative Concept]
   714 E C1705248:Component [Conceptual Entity]
   714 E C1947911:Combination [Physical Object]

Phrase: "by immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.77: In contrast to Sf9 cell membranes, PS1 polypeptides accumulated almost exclusively in the fragment forms, together with NCT, APH-1a, and PEN-2 in the BV fractions, only when all four components were infected (Fig. 2A, right lane). 

Phrase: "In contrast to Sf9 cell membranes,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   901   C0007603:Cell membranes [Cell Component]
   901   C3494245:Sf9 Cell [Cell]
   867 E C3161472:Cell Membrane [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0025255:Membranes [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "PS1 polypeptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "accumulated"

Phrase: "almost exclusively in the fragment forms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0332255:fragment [Functional Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C1708096:Fragment [Qualitative Concept]
   719 E C1522492:Form [Functional Concept]

Phrase: "together with NCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538913:APH-1A [Gene or Genome]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "PEN-2 in the BV fractions,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C3541303:PEN-2 [Gene or Genome]
   748   C0042776:Virus [Virus]
   748   C0319157:virus [Virus]
   748   C1264633:Fractions [Quantitative Concept]
   748   C3273588:Pen [Manufactured Object]
   714 E C1554103:Fraction [Idea or Concept]
   714   C2700462:Bud [Plant]
   714   C2945744:bud [Anatomical Structure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "all four components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "right lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.78: Co-immunoprecipitation studies revealed that amino-terminal fragment and carboxyl-terminal fragment of PS1 were associated as a heterodimer and formed a protein complex with NCT, APH-1, and PEN-2 in a similar manner to that in mammalian cells (Fig. 2B). 

Phrase: "Co-immunoprecipitation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that amino-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "carboxyl-terminal fragment of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "associated as a heterodimer"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0332281:Associated [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a protein complex with NCT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   806   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1523872:protein complex [Cell Component]
   797   C0960914:nicastrin protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "APH-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "PEN-2 in a similar manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3541303:PEN-2 [Gene or Genome]
   753   C2348205:Similar [Qualitative Concept]
   753   C3273588:Pen [Manufactured Object]

Phrase: "to that"

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.79: We next fractionated the Sf9 membranes and BV particles solubilized in CHAPSO by size-exclusion chromatography in 0.25% CHAPSO containing buffer, a condition in which solubilized membranes exhibit -secretase activity. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "the Sf9 membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "BV particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "solubilized in CHAPSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0055270:chapso [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "by size-exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "in 0.25% CHAPSO containing buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "a condition in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:condition [Disease or Syndrome]
   770   C0348080:Condition [Qualitative Concept]
   770   C1705253:Condition [Conceptual Entity]

Phrase: "solubilized"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "exhibit -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.80: Under this condition, PS1 fragments and -secretase activities in HeLa membranes were separated in fractions >1 megadalton, as described previously (26).2 Immunoblot analysis of the eluates of Sf9 cells and BV revealed that fragment forms of PS1 as well as other components were predominantly separated in fractions of HMW ranges >1 megadalton (Fig. 2C). 

Phrase: "Under this condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "PS1 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and -"

Phrase: "secretase activities in HeLa membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   764   C0596897:membrane activity [Cell Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "separated in fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C1264633:Fractions [Quantitative Concept]
   756 E C1554103:Fraction [Idea or Concept]

Phrase: ">1 megadalton,"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26"

Phrase: ").2 Immunoblot analysis of the eluates of Sf9 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "forms of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1522492:Form [Functional Concept]

Phrase: "as well as"

Phrase: "other components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "predominantly"

Phrase: "separated in fractions of HMW"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   814   C1979900:High molecular weight [Qualitative Concept]
   778   C0026385:Molecular Weight [Quantitative Concept]
   774   C0948775:high weight [Sign or Symptom]
   762   C1264633:Fraction of [Quantitative Concept]
           Fractions
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0086972:Separated [Finding]
   748   C0205250:High [Qualitative Concept]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1705104:Weight [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "ranges"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:*Ranges [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: ">1 megadalton"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.81: Similar results were obtained by glycerol velocity centrifugation (Fig. 1S). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained by glycerol velocity centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0439830:Velocity [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1547053:*Velocity [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(Fig. 1S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552115:1s [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.82: These data suggest that recombinant -secretase components undergo complex formation in Sf9 cells infected by baculovirus in a similar manner to that in mammalian cells, and that the HMW complex associated with PS1 fragments, but not a holoprotein, is selectively accumulated on BV particles. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that recombinant -secretase components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "undergo"

Phrase: "complex formation in Sf9 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "infected by baculovirus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0079005:Baculovirus [Virus]
   790   C0439663:Infected [Functional Concept]
   790   C0935640:Baculovirus [Virus]
   734 E C0376406:Granulosis Virus [Virus]

Phrase: "in a similar manner"

Phrase: "to that"

Phrase: "in mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the HMW complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "associated with PS1 fragments,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a holoprotein,"

Phrase: "is"

Phrase: "selectively"

Phrase: "accumulated on BV particles."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0042760:Virus Particles [Cell Component]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C0597177:particles [Chemical Viewed Structurally]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.83: Characterization of Reconstituted -Secretase Activity in Vitro in Sf9 Cell Membranes or on BVTo characterize the endogenous and reconstituted -secretase activities in Sf9 cells, we solubilized the Sf9 membranes with 1% CHAPSO and incubated them with the recombinant C100 substrate in vitro (12, 17). 

Phrase: "Characterization of Reconstituted -Secretase Activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in Vitro in Sf9 Cell Membranes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: "or on BVTo"

Phrase: "characterize"

Phrase: "the endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: "and"

Phrase: "reconstituted -"

Phrase: "secretase activities in Sf9 cells,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "solubilized"

Phrase: "the Sf9 membranes with 1% CHAPSO"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0025255:Membranes [Tissue]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "them with the recombinant C100 substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514798:recombinant [Organism]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.84: We did not detect any de novo generation of A peptides from the recombinant substrate in mock-infected Sf9 membranes, even in the presence of phosphatidylcholine (Fig. 3A, left), which increases in vitro -secretase activity in solubilized mammalian membranes (27).3 Some 42-secretase activity was observed, but this activity was not sensitive for -secretase inhibitors (see below). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any de novo generation of A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "from the recombinant substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "in mock-infected Sf9 membranes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "even in the presence of phosphatidylcholine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "in vitro -secretase activity in solubilized mammalian membranes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0596897:membrane activity [Cell Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(27"

Phrase: ").3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Some 42-secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "this activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not sensitive for -secretase inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332324:Sensitive [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.85: This was in agreement with the observation that Sf9 cells do not harbor an endogenous -secretase activity (24, 25). 

Phrase: "This"

Phrase: "was in agreement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0680240:Agreement [Social Behavior]
   790   C1421478:WAS [Gene or Genome]

Phrase: "with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "an endogenous -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.86: Overexpression of combinations of any three components did not reconstitute -secretase activities to elicit de novo A generation in vitro (data not shown), whereas overexpression of all four components exhibited a dramatic up-regulation of the proteolytic activity in Sf9 cell membranes (Fig 3A). 

Phrase: "Overexpression of combinations of any three components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reconstitute -"

Phrase: "secretase activities to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "de novo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515568:de novo [Idea or Concept]
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "overexpression of all four components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a dramatic up-regulation of the proteolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   769   C1514825:Regulation of Proteolysis [Molecular Function]
           Proteolytic Regulation
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "in Sf9 cell membranes"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   901   C0007603:Cell membranes [Cell Component]
   901   C3494245:Sf9 Cell [Cell]
   867 E C3161472:Cell Membrane [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0025255:Membranes [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig 3A"

Phrase: ")."
Processing 00000000.tx.87: Interestingly, A42 was the predominantly generated A species relative to A40 when we used Sf9 cells as an enzyme source, and the percentage of A42 as a fraction of de novo generated total A amounted to 60%. 

Phrase: "Interestingly,"

Phrase: "A42"

Phrase: "was"

Phrase: "the predominantly"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "relative to A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "when"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sf9 cells as an enzyme source,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C3494245:Sf9 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the percentage of A42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "as a fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "of de novo generated total A"

Phrase: "amounted to 60%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.88: We next analyzed the -secretase activity in CHAPSO-solubilized BV particles from multiply infected Sf9 cells and observed a robust A-generating activity in the BV fraction from cells infected with all four components. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the -secretase activity in CHAPSO-solubilized BV particles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "from multiply infected Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C3494245:Sf9 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a robust A-generating activity in the BV fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
   722   C0439161:Fractional activity [Quantitative Concept]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with all four components."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205450:Four [Quantitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.89: These activities were 10-fold higher than that detected in mammalian HeLa cell membranes, the latter harboring the highest level of endogenous -secretase activity in mammalian cells (Fig. 3B) (17). 

Phrase: "These activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "10-fold higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "detected in mammalian HeLa cell membranes,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0007603:Cell membranes [Cell Component]
   790   C0018873:HeLa cell [Cell]
           HeLa
   783   C1512977:Mammalian Cell [Cell]
   756 E C3161472:Cell Membrane [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0024660:Mammalian [Mammal]
   753   C0025255:Membranes [Tissue]
   753   C0442726:Detected [Finding]
   753   C1269647:Cell [Cell]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "the latter harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "the highest level of endogenous -secretase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0683317:Activity level [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.90: Similarly to the results in Sf9 membranes, A42 was again the predominant species in de novo generated A (%A42: mean  S.E., 65.5  7.1%). 

Phrase: "Similarly to the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in Sf9 membranes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "A42"

Phrase: "was"

Phrase: "again"

Phrase: "the predominant species in de novo generated A (%A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705920:Species [Conceptual Entity]

Phrase: ":"

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "65.5  7.1%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Coincubation with -secretase inhibitors, L-685,458 or DAPT, abolished the activity reconstituted in BV fractions (Fig. 3C). 

Phrase: "Coincubation with -secretase inhibitors,"

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "or"

Phrase: "DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "abolished"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "reconstituted in BV fractions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: Notably, reconstituted 42-secretase activity was less sensitive to L-685,458 at 100 nM concentration (65.2% inhibition), which completely abolished the -secretase activity in the HeLa membrane, whereas DAPT potently inhibited the 42-secretase activity (94.0% inhibition; residual activity was almost equivalent to that in mock-infected BV). 

Phrase: "Notably,"

Phrase: "reconstituted"

Phrase: "42-secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "less sensitive to L-685,458"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "at 100 nM concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(65.2% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished"

Phrase: "the -secretase activity in the HeLa membrane,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0596897:membrane activity [Cell Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "DAPT potently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0634829:dapt [Lipid]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the 42-secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(94.0% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "; residual activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "almost equivalent to that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]

Phrase: "in mock-infected BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042776:Virus [Virus]
   812   C0319157:virus [Virus]

Phrase: ")."
Processing 00000000.tx.93: These results indicate that -secretase activity can be reconstituted in Sf9 cells and BV associated with robust 42-cleavage activity by overexpression of all four components of human -secretase, as shown previously in other organisms (9-13). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "reconstituted in Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C3494245:Sf9 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "associated with robust 42-cleavage activity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0010813:cleavage [Cell Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C2986815:Robust [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "by overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of all four components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "of human -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously in other organisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0029235:Organisms [Organism]

Phrase: "(9-13"

Phrase: ")."
Processing 00000000.tx.94: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.96: Characterization of reconstituted -secretase activity. 

Phrase: "Characterization of reconstituted -secretase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.97: A, levels of de novo generated A40 () and A42 () (n = 2) generated from recombinant C100 by in vitro coincubation with solubilized Sf9 membranes infected with PS1, NCT-V5/His, APH-1a-myc/His, or His-PEN-2. 

Phrase: "A,"

Phrase: "levels of de novo generated A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "A42"

Phrase: "("

Phrase: ")"

Phrase: "(n = 2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "generated from recombinant C100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514798:recombinant [Organism]
   770   C3146294:Generated [Activity]

Phrase: "by in vitro coincubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "with solubilized Sf9 membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "infected with PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0439663:Infected [Functional Concept]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NCT-V5/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "His,"

Phrase: "APH-1a-myc/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538913:APH-1A [Gene or Genome]

Phrase: "His,"

Phrase: "or"

Phrase: "His-PEN-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]
Processing 00000000.tx.98: B, levels of A (n = 3, mean  S.E.) generated from recombinant C100 by in vitro coincubation with solubilized BV particles infected with various combinations of -secretase components. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "levels of A (n = 3,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456949:Level 3 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "generated from recombinant C100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514798:recombinant [Organism]
   770   C3146294:Generated [Activity]

Phrase: "by in vitro coincubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "with solubilized BV particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042760:Virus Particles [Cell Component]
   812   C0597177:particles [Chemical Viewed Structurally]

Phrase: "infected with various combinations of -secretase components."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439663:Infected [Functional Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0449432:Components [Manufactured Object]
   748   C0453882:Combinations [Manufactured Object]
   714 E C0205195:Combination [Qualitative Concept]
   714 E C1705248:Component [Conceptual Entity]
   714 E C1947911:Combination [Physical Object]
Processing 00000000.tx.99: HeLa cell membrane fraction was used as a control. 

Phrase: "HeLa cell membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0805525:Cell Fraction [Cell Component]
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "used as a control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.100: C, effect of -secretase inhibitors. 

Phrase: "C,"

Phrase: "effect of -secretase inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.101: Recombinant substrates were coincubated with solubilized BV or HeLa membrane in the presence of DAPT (100 M) or L-685,458 (100 nM). 

Phrase: "Recombinant substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "coincubated with solubilized BV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]

Phrase: "or"

Phrase: "HeLa membrane in the presence of DAPT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025255:Membrane [Tissue]
   748   C0596901:Membrane [Cell Component]
   748   C1706182:Membrane [Manufactured Object]

Phrase: "(100"

Phrase: "M)"

Phrase: "or"

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "(100 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.102: Both inhibitors inhibited the reconstituted -secretase activity.  

Phrase: "Both inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the reconstituted -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.103: We then examined the -secretase activity reconstituted by infection of mutant PS1 carrying D257A or D385A mutations, which is known to be inactive for PS1 endoproteolysis as well as for -secretase activity (28), together with the three cofactor proteins. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "reconstituted by infection of mutant PS1 carrying D257A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0009450:Infection, NOS [Disease or Syndrome]
   742   C0206243:Carrying [Activity]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   708 E C0699809:carry [Finding]

Phrase: "or"

Phrase: "D385A mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inactive for PS1 endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205254:Inactive [Qualitative Concept]

Phrase: "as well as for -secretase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205170:Well [Qualitative Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "together with the three cofactor proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.104: Recombinant PS1/D257A as well as PS1/D385A did not undergo endoproteolysis in Sf9 cells as well as in BV fractions (Fig. 4A), although they formed a >1-megadalton protein complex with other components (Fig. 4B). 

Phrase: "Recombinant PS1/D257A"

Phrase: "as well as"

Phrase: "PS1/D385A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "endoproteolysis in Sf9 cells"

Phrase: "as well as in BV fractions"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0042776:Virus [Virus]
   748   C0205170:Well [Qualitative Concept]
   748   C0319157:virus [Virus]
   748   C1264633:Fractions [Quantitative Concept]
   748   C3146287:Well [Manufactured Object]
   714 E C1554103:Fraction [Idea or Concept]
   714   C2700462:Bud [Plant]
   714   C2945744:bud [Anatomical Structure]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "they"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a >1-megadalton protein complex with other components"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   776   C1179436:Protein complex component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1523872:protein complex [Cell Component]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C1179435:Protein Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Reconstituted -secretase complex containing recombinant PS1/D257A or PS1/D385A showed almost no A-generating activity, whereas a low level of residual 42-secretase activity that was almost comparable with that in mock-infected BV was observed (Fig. 4C). 

Phrase: "Reconstituted -"

Phrase: "secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "recombinant PS1/D257A"

Phrase: "or"

Phrase: "PS1/D385A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "almost"

Phrase: "no A-generating activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "a low level of residual 42-secretase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0683317:Activity level [Finding]
   744   C0205251:low [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1299352:Low [Qualitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C1550472:low [Idea or Concept]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "was"

Phrase: "almost comparable with that"

Phrase: "in mock-infected BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042776:Virus [Virus]
   812   C0319157:virus [Virus]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: The identity of this endogenous, -secretase-like enzymatic activity should be examined further. 

Phrase: "The identity of this endogenous, -secretase-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "like enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "should"

Phrase: "be"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.107: Thus, intramembranous aspartates are required for endoproteolysis as well as for the A-generating enzymatic activity in a reconstituted -secretase complex in an insect cell system, similarly to that seen in mammalian cells (28). 

Phrase: "Thus,"

Phrase: "intramembranous aspartates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "required for endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "as well as for the A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "generating"

Phrase: "enzymatic activity in a reconstituted -secretase complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2267219:Enzymatic Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in an insect cell system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "similarly to that"

Phrase: "seen in mammalian cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.108: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 4. 

Phrase: "4."
Processing 00000000.tx.110: Characterization of reconstituted -secretase complex containing PS1 harboring aspartate mutations. 

Phrase: "Characterization of reconstituted -secretase complex containing PS1 harboring aspartate mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]
Processing 00000000.tx.111: A, immunoblot analysis of Sf9 membranes expressing aspartate mutant PS1 together with NCT-V5/His, APH-1amyc/His, His-PEN-2, or the BV particles. 

Phrase: "A,"

Phrase: "immunoblot analysis of Sf9 membranes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "expressing"

Phrase: "aspartate mutant PS1 together with NCT-V5/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "His,"

Phrase: "APH-1amyc/"

Phrase: "His,"

Phrase: "His-PEN-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "or"

Phrase: "the BV particles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]
Processing 00000000.tx.112: Note that PS1 fragments (arrowhead) were not detected in cell lysates or BV thereof infected with recombinant cDNA encoding aspartate mutant PS1. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that PS1 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "or"

Phrase: "BV thereof"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "infected with recombinant cDNA encoding aspartate mutant PS1."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439663:Infected [Functional Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1514798:recombinant [Organism]
   742   C1547699:Encoding [Idea or Concept]
   742   C2700640:Encoding [Activity]
Processing 00000000.tx.113: wt, wild type. 

Phrase: "wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.114: B, separation of mutant -secretase complex by gel filtration. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "separation of mutant -secretase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "by gel filtration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]
Processing 00000000.tx.115: Note that mutant PS1 holoproteins were detected within fractions with molecular masses over 1 megadalton. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that mutant PS1 holoproteins"

Phrase: "were"

Phrase: "detected within fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1264633:Fractions [Quantitative Concept]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C1554103:Fraction [Idea or Concept]

Phrase: "with molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "over 1 megadalton."
Processing 00000000.tx.116: C, -secretase activity of reconstituted aspartate-mutant -secretase complex (n = 3, mean  S.E.). 

Phrase: "C, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "secretase activity of reconstituted aspartate-mutant -secretase complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ")."
Processing 00000000.tx.117: Mutation in either of the aspartates virtually abolished the -secretase activity in vitro. wt, wild type.  

Phrase: "Mutation in either of the aspartates virtually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolished"

Phrase: "the -secretase activity in vitro. wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2700323:WT [Fish]

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.118: -Secretase cleaves several type I membrane proteins other than APP, including Notch, at multiple sites within the transmembrane domain and liberate the ICD (7). 

Phrase: "-Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "several type I membrane proteins other than APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   760   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   741   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0025255:Membrane [Tissue]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0596901:Membrane [Cell Component]
   739   C1706182:Membrane [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Notch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "at multiple sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "within the transmembrane domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "liberate"

Phrase: "the ICD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.119: To examine whether reconstituted -secretase activity in BV cleaves other substrates, we examined the ICD generation from recombinant APP or Notch carboxyl-terminal fragments (C100 and N102, respectively (17)) using the BV particles as the source of -secretase in vitro. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "reconstituted -secretase activity in BV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "cleaves"

Phrase: "other substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ICD generation from recombinant APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "or"

Phrase: "Notch carboxyl-terminal fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "(C100"

Phrase: "and"

Phrase: "N102,"

Phrase: "respectively"

Phrase: "(17"

Phrase: ")"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BV particles as the source of -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0042760:Virus Particles [Cell Component]
   742   C0597177:particles [Chemical Viewed Structurally]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.120: The recombinant substrates were cleaved to generate ICDs by the -secretase activity from BV fractions of Sf9 cells infected with all four components, which were sensitive to -secretase inhibitors, in a similar manner to those with HeLa-derived -secretase (Fig. 5). 

Phrase: "The recombinant substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "ICDs by the -secretase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162589:icds [Medical Device]

Phrase: "from BV fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "of Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "infected with all four components,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205450:Four [Quantitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "which"

Phrase: "were"

Phrase: "sensitive to -secretase inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "in a similar manner"

Phrase: "to those with HeLa-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018873:HeLa [Cell]

Phrase: "derived -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: Finally, we compared the -secretase activities in solubilized BV particles and in Sf9 membranes. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the -secretase activities in solubilized BV particles"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "and in Sf9 membranes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C1515981:And [Idea or Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.122: When normalized by the expression levels of the PS1 amino-terminal fragment, the relative -secretase activity in BV particles was increased by 2.5 fold compared with that of solubilized Sf9 cell membranes, suggesting that the -secretase active form of PS1 fragments was enriched in BV fractions (Fig. 6). 

Phrase: "When"

Phrase: "normalized by the expression levels of the PS1 amino-terminal fragment,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   753   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418985:PRESENILIN 1 [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205088:Terminal [Temporal Concept]
   736   C0332255:fragment [Functional Concept]
   736   C0441889:Levels [Qualitative Concept]
   736   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1708096:Fragment [Qualitative Concept]
   736   C1882115:Normalized [Research Activity]
   734   C0456947:Level 1 [Intellectual Product]
   719   C3244092:expression level [Idea or Concept]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "the relative -secretase activity in BV particles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased by 2.5 fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with that of solubilized Sf9 cell membranes,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007603:Cell membranes [Cell Component]
   770   C3494245:Sf9 Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0025255:Membranes [Tissue]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1707455:Compared [Activity]
   744   C1948049:Cell [Spatial Concept]
   737 E C3161472:Cell Membrane [Cell Component]
   711 E C0596901:Membrane [Cell Component]
   711 E C1706182:Membrane [Manufactured Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -secretase active form of PS1 fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "enriched in BV fractions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C0359583:enriched [Food]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: Thus, we were able to reconstitute the -secretase complex in BV membranes. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reconstitute"

Phrase: "the -secretase complex in BV membranes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.124: This complex contained the fragment forms of PS1 and was enriched in proteolytic activity. 

Phrase: "This complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "forms of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "enriched in proteolytic activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205177:Activity [Functional Concept]
   770   C0359583:enriched [Food]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1561536:*Activity [Idea or Concept]
   770   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.125: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.126: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.127: Reconstituted -secretase activities for ICD generation. 

Phrase: "Reconstituted -"

Phrase: "secretase activities for ICD generation."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.128: Recombinant substrates were incubated at 4 C (-) or 37 C (+) with solubilized membrane fractions from mock-infected BV (mock), BV infected with all four components (reconstituted BV), or HeLa cell membrane in the presence of dimethyl sulfoxide (DMSO), DAPT (100 M), or L-685,458 (100 nM), respectively. 

Phrase: "Recombinant substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "incubated at 4 C (-)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "37 C (+) with solubilized membrane fractions"

Phrase: "from mock-infected BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042776:Virus [Virus]
   812   C0319157:virus [Virus]

Phrase: "(mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: ","

Phrase: "BV infected with all four components"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1268456:Virus Components [Cell Component]
   748   C0042776:Virus [Virus]
   748   C0319157:virus [Virus]
   748   C0439663:Infected [Functional Concept]

Phrase: "(reconstituted BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "HeLa cell membrane in the presence of dimethyl sulfoxide (DMSO),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0007603:Cell Membrane [Cell Component]
   764   C3161472:Cell Membrane [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]

Phrase: "DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "(100"

Phrase: "M)"

Phrase: ","

Phrase: "or"

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "(100 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.129: Resultant samples were analyzed by immunoblotting using anti-myc (APP) or anti-cleaved Notch1 (Val1744) antibodies. 

Phrase: "Resultant samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-myc (APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "anti-cleaved Notch1"

Phrase: "(Val1744"

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.130: AICD, APP ICD; 

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "APP ICD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.131: NICD, Notch ICD.  

Phrase: "NICD,"

Phrase: "Notch ICD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.132: View larger version (11K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 6. 

Phrase: "6."
Processing 00000000.tx.134: Comparison of -secretase activities in solubilized Sf9 cell membranes (Sf9) and BV particles (BV). 

Phrase: "Comparison of -secretase activities in solubilized Sf9 cell membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0441655:Activities [Activity]
   728   C0596897:membrane activity [Cell Function]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "(Sf9"

Phrase: ")"

Phrase: "and"

Phrase: "BV particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "(BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: ")."
Processing 00000000.tx.135: Relative -secretase activities (that of Sf9 cell membrane = 1) were evaluated by the amount of A1-40 generated from recombinant C100 (as measured by ELISA) and normalized by the levels of PS1 amino-terminal fragment (as quantified by densitometric analysis (n = 3, mean  S.E.)).   

Phrase: "Relative -secretase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "that of Sf9 cell membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007603:Cell Membrane [Cell Component]
   806   C3161472:Cell Membrane [Cell Component]
   806   C3494245:Sf9 Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1706182:Membrane [Manufactured Object]
   760   C1948049:Cell [Spatial Concept]

Phrase: "= 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "evaluated by the amount of A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220825:Evaluated [Functional Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C1265611:Amount [Quantitative Concept]

Phrase: "generated from recombinant C100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514798:recombinant [Organism]
   770   C3146294:Generated [Activity]

Phrase: "("

Phrase: "as"

Phrase: "measured by ELISA)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "normalized by the levels of PS1 amino-terminal fragment"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   741   C0456947:Level 1 [Intellectual Product]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1882115:Normalized [Research Activity]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "quantified by densitometric analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: ")."
Processing 00000000.tx.136: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In this study, we selectively reconstituted and recovered human -secretase complex in an active form, using BV particles. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we selectively"

Phrase: "reconstituted"

Phrase: "and"

Phrase: "recovered human -secretase complex in an active form,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BV particles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042760:Virus Particles [Cell Component]
   827   C0597177:particles [Chemical Viewed Structurally]
Processing 00000000.tx.137: The baculovirus/insect cell system is one of the most widely used methodologies for overexpression of recombinant proteins, including multispan integral membrane proteins (reviewed by Massotte (1)). 

Phrase: "The baculovirus/insect cell system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "one of the most widely used methodologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "for overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of recombinant proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "multispan integral membrane proteins"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   861   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443238:Integral [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "reviewed by Massotte"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.138: We used this system for the reconstitution of -secretase, a pivotal enzyme for the generation of A peptides in Alzheimer's disease brains. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this system for the reconstitution of -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "a pivotal enzyme for the generation of A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "in Alzheimer's disease brains."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.139: We found that -secretase complex is reconstituted in membrane fractions of Sf9 cells infected with PS1, NCT, APH-1, and PEN-2 in an active state, showing similar metabolic and enzymatic properties to those in mammalians cells. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "reconstituted in membrane fractions of Sf9 cells"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   778   C3494245:Sf9 Cells [Cell]
   774   C0007603:cells membrane [Cell Component]
   762   C1264633:Fraction of [Quantitative Concept]
           Fractions
   757   C0805525:Cell fractions [Cell Component]
   757 E C3161472:Cell Membrane [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0025255:Membrane [Tissue]
   748   C0596901:Membrane [Cell Component]
   748   C1706182:Membrane [Manufactured Object]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1554103:Fraction [Idea or Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "infected with PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0439663:Infected [Functional Concept]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "APH-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "PEN-2 in an active state,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0679217:active state [Finding]
   790   C3541303:PEN-2 [Gene or Genome]
   753   C0205177:Active [Functional Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   753   C3273588:Pen [Manufactured Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "enzymatic properties to those in mammalians cells."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]
Processing 00000000.tx.140: The requirement of the expression of all four components for the reconstitution of -secretase complex and its activity, which was demonstrated previously in yeast (13), suggests that Sf9 cells do not harbor endogenous cofactor proteins that can efficiently form complexes with the exogenous human PS1. 

Phrase: "The requirement of the expression of all four components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514873:Requirement [Functional Concept]

Phrase: "for the reconstitution of -secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "its activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "previously in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "endogenous cofactor proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "can"

Phrase: "efficiently"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "complexes with the exogenous human PS1."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.141: Even with the co-infection of all four components, however, a majority of exogenous PS1 remained in a holoprotein form, and relatively small amounts of PS1 fragments were generated in Sf9 membranes, similarly to overexpression systems using other organisms, including yeast (9-13). 

Phrase: "Even with the co-infection of all four components,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   764   C0275524:Co-infection [Disease or Syndrome]
   742   C0009450:Infection, NOS [Disease or Syndrome]
   742   C0205450:Four [Quantitative Concept]
   742   C0449432:Components [Manufactured Object]
   708 E C1705248:Component [Conceptual Entity]

Phrase: "however,"

Phrase: "a majority of exogenous PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "remained in a holoprotein form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "relatively small amounts of PS1 fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "generated in Sf9 membranes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C3146294:Generated [Activity]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "similarly to overexpression systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1514559:Overexpression [Genetic Function]
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other organisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029235:Organisms [Organism]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(9-13"

Phrase: ")."
Processing 00000000.tx.142: Recent reports that G-protein-coupled receptors can be reconstituted in a functional form, recruiting endogenous G subunit or adenylyl cyclase as interactors in the extracellular BV particles released from infected Sf9 cells (2), prompted us to apply this strategy to the effective reconstitution of -secretase composed of multiple integral membrane proteins. 

Phrase: "Recent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recent [Temporal Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that G-protein-coupled receptors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "can"

Phrase: "be"

Phrase: "reconstituted in a functional form,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205245:Functional [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0542341:Functional [Functional Concept]
   760   C1522492:Form [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]

Phrase: "recruiting"

Phrase: "endogenous G subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "or"

Phrase: "adenylyl cyclase as interactors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the extracellular BV particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042760:Virus Particles [Cell Component]
   812   C0597177:particles [Chemical Viewed Structurally]

Phrase: "released from infected Sf9 cells"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   806   C3494245:Sf9 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0391871:Released [Functional Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1283071:Released [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "this strategy to the effective reconstitution of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0679199:strategy [Mental Process]

Phrase: "composed of multiple integral membrane proteins."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0443238:Integral [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.143: Surprisingly, BV fractions from Sf9 cells infected with all four components almost exclusively contained the -secretase complex harboring PS1 fragments, with minimal contamination of nascent or misfolded PS1 holoproteins. 

Phrase: "Surprisingly,"

Phrase: "BV fractions from Sf9 cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0805525:Cell fractions [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "infected with all four components almost exclusively"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0205450:Four [Quantitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the -secretase complex harboring PS1 fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "with minimal contamination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "of nascent"

Phrase: "or"

Phrase: "misfolded PS1 holoproteins."
Processing 00000000.tx.144: Reconstituted -secretase on BV again reproduced similar biochemical and enzymatic properties to those in mammalian cells (i.e. HMW protein complex formation, inhibition by -secretase inhibitors, requirement of the transmembrane aspartates, and cleavage of both APP and Notch). 

Phrase: "Reconstituted -"

Phrase: "secretase on BV again"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reproduced"

Phrase: "similar biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "enzymatic properties to those in mammalian cells"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "(i.e. HMW protein complex formation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1158923:protein complex formation [Molecular Function]
   822   C0597295:protein formation [Molecular Function]
   793   C0220781:formation [Biologic Function]
   793   C0439634:formation [Spatial Concept]
   793   C1522492:Formation [Functional Concept]

Phrase: "inhibition by -secretase inhibitors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "requirement of the transmembrane aspartates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "cleavage of both APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: ")."
Processing 00000000.tx.145: The mechanism whereby reconstituted -secretase in Sf9 cells or BV shifted the de novo generation of A to A42 species remains unclear, but it is highly reminiscent of the overproduction of A42 by expression of wild-type Drosophila PS in mammalian cells, which predominantly generates A40 in Drosophila cells (23); 

Phrase: "The mechanism whereby"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "reconstituted -"

Phrase: "secretase in Sf9 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the de novo generation of A to A42 species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "remains"

Phrase: "unclear,"

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "highly reminiscent of the overproduction of A42"

Phrase: "by expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of wild-type Drosophila PS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which predominantly"

Phrase: "generates"

Phrase: "A40 in Drosophila cells"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.146: the three-dimensional structure of the catalytic pocket of -secretase, which determines the positions of the preferred -secretase cleavage site, may be altered depending on the cell species or the environment surrounding the enzyme complex. 

Phrase: "the three-dimensional structure of the catalytic pocket of -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0450363:3-Dimensional [Spatial Concept]
   739   C0205449:Three [Quantitative Concept]
   739   C0678594:Structure [Spatial Concept]

Phrase: "which"

Phrase: "determines"

Phrase: "the positions of the preferred -secretase cleavage site,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0733755:positions [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "depending on the cell species"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705920:Species [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
   726   C0725813:depend [Medical Device]

Phrase: "or"

Phrase: "the environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environment [Spatial Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the enzyme complex."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.147: Moreover, very high -secretase activity (10 fold that of mammalian HeLa cells) was recovered in BV. 

Phrase: "Moreover,"

Phrase: "very high -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(10 fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "that of mammalian HeLa cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0018873:HeLa Cells [Cell]
           HeLa
   781   C1512977:Mammalian Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0024660:Mammalian [Mammal]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "recovered in BV."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   770   C0521108:recovered [Qualitative Concept]
   737 E C2004454:recover [Organism Function]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.148: Notably, the relative -secretase activity standardized by the levels of PS1 fragments also was higher than that in the Sf9 cell membrane. 

Phrase: "Notably,"

Phrase: "the relative -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "standardized by the levels of PS1 fragments also"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   745   C0456947:Level 1 [Intellectual Product]
   742   C0332255:fragments [Functional Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0486805:Fragments [Body Substance]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C1708096:Fragment [Qualitative Concept]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in the Sf9 cell membrane."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   901   C0007603:Cell Membrane [Cell Component]
   901   C3161472:Cell Membrane [Cell Component]
   901   C3494245:Sf9 Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1706182:Membrane [Manufactured Object]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.149: This supports the notion that a limited proportion of HMW protein complex composed of the four components is -secretase-active, as suggested by the limited recovery of active -secretase complex using activity-dependent purification (29, 30), and that some additional factors or conditions are necessary for the full activation of -secretase (31). 

Phrase: "This"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that"

Phrase: "a limited proportion of HMW protein complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709707:Proportion [Quantitative Concept]

Phrase: "composed of the four components is -secretase-active,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Active [Functional Concept]
   744   C0205450:Four [Quantitative Concept]
   744   C0449432:Components [Manufactured Object]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "as"

Phrase: "suggested by the limited recovery of active -secretase complex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205177:Active [Functional Concept]
   742   C0237820:Recovery [Activity]
   742   C0439801:Limited [Functional Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C1555688:recovery [Idea or Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C2004454:Recovery [Organism Function]
   742   C3542948:Limited [Intellectual Product]
   708   C1705535:Suggest [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "activity-dependent purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that"

Phrase: "some additional factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "necessary for the full activation of -secretase"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: The mechanism whereby "active form" -secretase complex containing PS1 fragments is selectively accumulated on BV is unknown. 

Phrase: "The mechanism whereby ""active form"" -secretase complex containing PS1 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332255:fragments [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   756 E C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "selectively"

Phrase: "accumulated on BV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.151: One possibility would be that the BV envelope may preferentially recruit membranes derived from plasma membrane or late intracellular membrane compartments, which are enriched in an active form of -secretase (32-34). 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "that"

Phrase: "the BV envelope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0178887:virus envelope [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1622204:envelope [Cell Component]

Phrase: "may"

Phrase: "preferentially"

Phrase: "recruit"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "derived from plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007603:Plasma membrane [Cell Component]
   770   C0025255:Membrane [Tissue]
   770   C0032105:Plasma [Body Substance]
   770   C0596901:Membrane [Cell Component]
   770   C1441547:Derived [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1706182:Membrane [Manufactured Object]
   770   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "late intracellular membrane compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1185625:Compartments [Body Space or Junction]
   812   C1382196:Compartments [Natural Phenomenon or Process]
   779 E C2986730:Compartment [Spatial Concept]

Phrase: "which"

Phrase: "are"

Phrase: "enriched in an active form of -secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Active [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0359583:enriched [Food]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "(32-34"

Phrase: ")."
Processing 00000000.tx.152: However, the observation that endoplasmic reticulum-resident membrane proteins, such as SREBP or SREBP cleavage-activating protein, can be recovered on BV as well (4) may argue against this view. 

Phrase: "However,"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that endoplasmic reticulum-resident membrane proteins,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   888   C0230770:endoplasmic reticulum membrane [Cell Component]
   840   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "such as SREBP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   858   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C2246292:sterol binding [Molecular Function]
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0038323:Sterol [Steroid]
   799   C0220905:regulatory [Regulation or Law]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704735:Regulatory [Conceptual Entity]
   799   C1705248:Element [Conceptual Entity]

Phrase: "or"

Phrase: "SREBP cleavage-activating protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   733   C1327378:sterol regulatory element binding protein cleavage [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "recovered on BV"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   770   C0521108:recovered [Qualitative Concept]
   737 E C2004454:recover [Organism Function]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(4"

Phrase: ")"

Phrase: "may"

Phrase: "argue against this view."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449911:View [Spatial Concept]
Processing 00000000.tx.153: Folding, complex formation, and functions of integral membrane proteins may be properly achieved on BV, based on some unknown mechanism specific to the life cycle of baculovirus. 

Phrase: "Folding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "complex formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "functions of integral membrane proteins"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   862   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0682568:functions membrane [Body Part, Organ, or Organ Component]
   797   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   781 E C1527118:Protein Function [Molecular Function]
   760   C0025255:Membrane [Tissue]
   760   C0031843:function [Physiologic Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443238:Integral [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "properly"

Phrase: "achieved on BV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "based on some unknown mechanism"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0439673:Unknown [Qualitative Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1706376:Mechanism [Manufactured Object]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "specific to the life cycle of baculovirus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.154: Intriguingly, the major phospholipid consisting of BV envelope is phosphatidylserine, whereas phosphatidylcholine and phosphatidylethanolamine are the major phospholipids in host Sf 9 cells (35-37). 

Phrase: "Intriguingly,"

Phrase: "the major phospholipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   861   C0202177:Phospholipid [Laboratory Procedure]

Phrase: "consisting of BV envelope"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0178887:virus envelope [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C1622204:envelope [Cell Component]
   726   C0332529:CONSIST [Qualitative Concept]
   726   C2700462:Bud [Plant]
   726   C2945744:bud [Anatomical Structure]

Phrase: "is"

Phrase: "phosphatidylserine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "whereas"

Phrase: "phosphatidylcholine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphatidylethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "are"

Phrase: "the major phospholipids in host Sf 9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   829   C1819995:Host Cell [Cell Component]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "(35-37"

Phrase: ")."
Processing 00000000.tx.155: Recently, palmitoylation of GP64 protein, which is highly abundant and necessary for efficient budding and production of BV as well as its entry into host cells, was reported (38). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "palmitoylation of GP64 protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1157492:protein palmitoylation [Molecular Function]
   770   C0598435:Palmitoylation [Molecular Function]

Phrase: "which"

Phrase: "is"

Phrase: "highly abundant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "necessary for efficient budding"

Phrase: "and"

Phrase: "production of BV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "as well as"

Phrase: "its entry into host cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   918   C1659441:entry into host cell [Pathologic Function]
   862   C1656970:entry into host [Biologic Function]
   760   C1705654:Entry [Intellectual Product]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.156: However, GP64 was not detected in lipid rafts in Sf9 cells, and its palmitoylation did not affect the apparent exclusion of GP64 from lipid rafts, although lipid rafts have been shown to play roles in the infection cycles of several viruses (e.g. HIV-1 and influenza virus) (39). 

Phrase: "However,"

Phrase: "GP64"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in lipid rafts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1167250:lipid rafts [Cell Component]
   770   C0023779:Lipid [Lipid]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0336849:Raft [Manufactured Object]

Phrase: "in Sf9 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "its palmitoylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598435:Palmitoylation [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the apparent exclusion of GP64"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "from lipid rafts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167250:lipid rafts [Cell Component]
   827   C0336849:Raft [Manufactured Object]

Phrase: "although"

Phrase: "lipid rafts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167250:lipid rafts [Cell Component]
   827   C0336849:Raft [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "roles in the infection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "cycles of several viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042776:Viruses [Virus]
   770   C0521026:viruses [Functional Concept]
   770   C1511572:Cycle [Temporal Concept]
   737 E C0319157:virus [Virus]

Phrase: "("

Phrase: "e.g. HIV-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019704:HIV-1 [Virus]
   861   C0019682:HIV [Virus]
   861   C0019699:HIV+ [Finding]

Phrase: "and"

Phrase: "influenza virus"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0029341:Influenza virus [Virus]
   861   C0021400:Influenza [Disease or Syndrome]
   861   C0021403:INFLUENZA [Immunologic Factor,Pharmacologic Substance]
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]
   768 E C0220843:Grip [Organism Function]

Phrase: ")"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.157: These results may suggest that specific membrane domains other than rafts may be involved in baculovirus budding as well as in the effective formation of a functional protein complex in Sf9 cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that specific membrane domains other than rafts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "involved in baculovirus budding"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0079005:Baculovirus [Virus]
   770   C0935640:Baculovirus [Virus]
   770   C1155616:budding [Cell Function]
   770   C1314939:Involved [Functional Concept]
   737 E C2700462:Bud [Plant]
   737 E C2945744:bud [Anatomical Structure]
   715 E C0376406:Granulosis Virus [Virus]

Phrase: "as well as in the effective formation of a functional protein complex"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   767   C1158923:protein complex formation [Molecular Function]
   753   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1523872:protein complex [Cell Component]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C0597295:protein formation [Molecular Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205170:Well [Qualitative Concept]
   736   C0205245:Functional [Functional Concept]
   736   C0220781:formation [Biologic Function]
   736   C0439634:formation [Spatial Concept]
   736   C0439855:Complex [Qualitative Concept]
   736   C0542341:Functional [Functional Concept]
   736   C1280519:effective [Qualitative Concept]
   736   C1522492:Formation [Functional Concept]
   736   C1704241:Complex [Chemical Viewed Structurally]
   736   C1704419:Effective [Qualitative Concept]
   736   C2700217:Functional [Conceptual Entity]
   736   C3146287:Well [Manufactured Object]

Phrase: "in Sf9 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.158: We and others have reconstituted the -secretase complex by overexpression of the four components in mammalian, Drosophila, or yeast cells (10-13). 

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "reconstituted"

Phrase: "the -secretase complex by overexpression of the four components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in mammalian, Drosophila,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013138:Drosophila [Eukaryote]
   861   C1028876:Drosophila [Fungus]
   861   C1504613:Drosophila [Eukaryote]

Phrase: "or"

Phrase: "yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(10-13"

Phrase: ")."
Processing 00000000.tx.159: However, the enzymatic activity in BV was by far higher than those in mammalian or Drosophila cells (Fig. 3B and data not shown). 

Phrase: "However,"

Phrase: "the enzymatic activity in BV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2267219:Enzymatic Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was by far higher"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0205108:far [Spatial Concept]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than those"

Phrase: "in mammalian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammalian [Mammal]

Phrase: "or"

Phrase: "Drosophila cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: Considering the previous observations on the effective incorporation of endogenous proteins into the functional protein complex (e.g. exogenous G-protein coupled receptor and endogenous G protein) observed in BV (2), it is possible that the -secretase complex reconstituted in BV incorporated relevant binding partner proteins that were endogenously present in BV, resulting in the formation of a "hyperactive" enzyme complex. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the previous observations on the effective incorporation of endogenous proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C0302523:observations [Research Activity]
   739   C0700325:observations [Health Care Activity]
   739   C3244290:observations [Functional Concept]
   706 E C1964257:Observation [Diagnostic Procedure]

Phrase: "into the functional protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "("

Phrase: "e.g. exogenous G-protein coupled receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   840   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439267:g% [Quantitative Concept]
   804   C1948027:Coupled [Functional Concept]
   771 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "endogenous G protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "observed in BV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   770   C1441672:Observed [Functional Concept]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the -secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "reconstituted in BV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "incorporated"

Phrase: "relevant binding partner proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "were"

Phrase: "endogenously"

Phrase: "present in BV,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0042776:Virus [Virus]
   770   C0150312:Present [Quantitative Concept]
   770   C0319157:virus [Virus]
   770   C0449450:Present [Idea or Concept]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]

Phrase: "resulting in the formation of a ""hyperactive"" enzyme complex."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0332294:Resulting in [Functional Concept]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0220781:formation [Biologic Function]
   742   C0424295:Hyperactive [Finding]
   742   C0439634:formation [Spatial Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]
Processing 00000000.tx.161: Approximately 30 proteins have been identified by SDS-PAGE and Coomassie blue staining in the BV envelope (35). 

Phrase: "Approximately 30 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "Coomassie blue staining in the BV envelope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.162: Recently, proteomic analysis of the occlusion-derived form of baculovirus was reported, although similar data on BV have not been publicized yet (40). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "proteomic analysis of the occlusion-derived form of baculovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "although"

Phrase: "similar data on BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "publicized"

Phrase: "yet"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.163: Thus, it would be possible to identify the missing interacting partners of the PS complex in Sf9 proteins based on proteomic analysis of the -secretase reconstituted on BV. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "identify"

Phrase: "the missing interacting partners of the PS complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0682323:partners [Family Group]

Phrase: "in Sf9 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "based on proteomic analysis of the -secretase"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0872252:proteomic [Biomedical Occupation or Discipline]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "reconstituted on BV."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]
   737   C2700462:Bud [Plant]
   737   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.164: Other possible applications of the reconstituted -secretase on BV may include production of active form-specific or blocking antibodies against -secretase and generation of an immobilized -secretase as a biochip sensor that may be applicable to large-scale screening of physiological interactors or low-molecular-weight compounds for drug discovery (4).4 A number of integral membrane proteins with important functions, including ion channels or receptor proteins, form hetero-multimeric protein complexes (1). 

Phrase: "Other possible applications of the reconstituted -secretase"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0185125:applications [Health Care Activity]
   714 E C1947919:Application [Intellectual Product]
   714 E C2347934:Application [Intellectual Product]
   714 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "on BV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "production of active form-specific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "blocking antibodies against -secretase"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0282682:Antibodies, Blocking [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "generation of an immobilized -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "as a biochip sensor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183210:Sensor [Medical Device]
   861   C1705193:Sensor [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "applicable to large-scale screening of physiological interactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272460:applicable [Qualitative Concept]
   744   C1706839:Applicable [Qualitative Concept]

Phrase: "or"

Phrase: "low-molecular-weight compounds for drug discovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0013164:compounds drug [Health Care Activity]
   714   C0205198:Compound [Qualitative Concept]
   714   C1706082:Compound [Chemical]

Phrase: "(4"

Phrase: ").4"

Phrase: "A number of integral membrane proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "with important functions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "or"

Phrase: "receptor proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597357:receptor proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form hetero-multimeric protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1523872:protein complex [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.165: Purification of a large quantity of protein complex in a biologically active state is indispensable to the biochemical, functional, and especially structural studies of these complexes. 

Phrase: "Purification of a large quantity of protein complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597301:protein purification [Laboratory Procedure]
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "in a biologically active state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0679217:active state [Finding]
   827   C0205177:Active [Functional Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "is"

Phrase: "indispensable to the biochemical, functional,"

Phrase: "and"

Phrase: "especially structural studies of these complexes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0678594:Structural [Spatial Concept]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.166: The purification procedures presented in this report for recombinant membrane proteins in an active form in BV fractions, recovered from multiply infected Sf9 cells, should provide a versatile methodology for the characterization of various integral membrane protein complexes. 

Phrase: "The purification procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "presented in this report"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0449450:Presented [Idea or Concept]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "for recombinant membrane proteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "in an active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "in BV fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "recovered from multiply infected Sf9 cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C3494245:Sf9 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0439663:Infected [Functional Concept]
   753   C0521108:recovered [Qualitative Concept]
   753   C1719797:Multiply [Functional Concept]
   753   C2911648:Multiply [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "should"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a versatile methodology for the characterization of various integral membrane protein complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0969625:methodology [Intellectual Product]
   736   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.167: It should also open up the way to one of the ultimate goals in -secretase researchto crystallize the complex and unravel its three-dimensional structure in an active state.  

Phrase: "It"

Phrase: "should"

Phrase: "also"

Phrase: "open up the way"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0175566:Open [Spatial Concept]

Phrase: "to one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of the ultimate goals in -secretase researchto"

Phrase: "crystallize"

Phrase: "the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "unravel"

Phrase: "its three-dimensional structure in an active state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450363:3-Dimensional [Spatial Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.168: FOOTNOTES  * This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology for the 21st Century Center of Excellence Program and by the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research, Japan. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants-in-aid"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0018173:Grants [Quantitative Concept]
   760   C0018896:Aid [Social Behavior]
   760   C0449435:Aid [Manufactured Object]
   760   C1521721:Supported [Conceptual Entity]
   760   C3540469:AID [Gene or Genome]
   726 E C0183683:Support [Medical Device]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology for the 21st Century Center of Excellence Program"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0039421:Technology [Occupation or Discipline]

Phrase: "and by the Program"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1515981:And [Idea or Concept]
   770   C1709697:Program [Conceptual Entity]
   770   C2728259:Program [Pharmacologic Substance]
   770   C3484370:Program [Functional Concept]

Phrase: "for Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of Fundamental Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in Health Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "of the Organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0029237:Organisation [Physiologic Function]
  1000   C0029246:Organization [Organization]
  1000   C0220885:organization [Qualitative Concept]
  1000   C1300196:Organization [Functional Concept]
  1000   C1522486:Organization [Professional or Occupational Group]

Phrase: "for Pharmaceutical Safety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036043:Safety [Human-caused Phenomenon or Process]
   861   C1705187:SAFETY [Research Activity]

Phrase: "and"

Phrase: "Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.169: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.170: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.171: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.172: The on-line version of this article (available at http://www.jbc.org) contains Fig. 

Phrase: "The on-line version of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "(available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jbc.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 1S.  

Phrase: "1S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552115:1s [Body Part, Organ, or Organ Component]
Processing 00000000.tx.174: To whom correspondence should be addressed: Dept. of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "7-3-1 Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.175: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.176: 81-3-5841-4877; 

Phrase: "81-3-5841-4877"

Phrase: ";"
Processing 00000000.tx.177: Fax: 81-3-5841-4708; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-3-5841-4708"

Phrase: ";"
Processing 00000000.tx.178: E-mail: taisuke{at}mol.f.u-tokyo.ac.jp or iwatsubo{at}mol.f.u-tokyo.ac.jp . 1 The abbreviations used are: BV, budded virus; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "taisuke{at}mol.f.u-tokyo.ac.jp"

Phrase: "or"

Phrase: "iwatsubo{at}mol.f.u-tokyo.ac.jp . 1"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   807   C1422482:JP-1 [Gene or Genome]
   791   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   791   C0027960:Mole [Neoplastic Process]
   791   C0040371:Tokyo [Geographic Area]
   791   C0324740:Mole [Mammal]
   791   C0439133:(f) [Intellectual Product]
   791   C0439189:Mole [Quantitative Concept]
   791   C1412573:AC [Gene or Genome]
   791   C1456781:mole [Neoplastic Process]
   791   C1553038:[f] [Quantitative Concept]
   791   C1824986:mol [Gene or Genome]
   791   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   791   C3539770:AC [Gene or Genome]
   708 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "BV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "budded virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: ";"
Processing 00000000.tx.179: SREBP, sterol regulatory element-binding protein-2; 

Phrase: "SREBP,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   858   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C2246292:sterol binding [Molecular Function]
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0038323:Sterol [Steroid]
   799   C0220905:regulatory [Regulation or Law]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704735:Regulatory [Conceptual Entity]
   799   C1705248:Element [Conceptual Entity]

Phrase: "sterol regulatory element-binding protein-2"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0250036:Sterol Regulatory Element Binding Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420399:STEROL REGULATORY ELEMENT-BINDING PROTEIN 2 [Gene or Genome]
   858   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C2246292:sterol binding [Molecular Function]
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0038323:Sterol [Steroid]
   799   C0220905:regulatory [Regulation or Law]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704735:Regulatory [Conceptual Entity]
   799   C1705248:Element [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.180: PS, presenilin; 

Phrase: "PS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.181: NCT, nicastrin; 

Phrase: "NCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.182: APP, amyloid- precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid- precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.183: A, amyloid peptide; 

Phrase: "A,"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.184: ICD, intracellular domain; 

Phrase: "ICD,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "intracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.185: HMW, high molecular weight; 

Phrase: "HMW, high molecular weight"

Phrase: ";"
Processing 00000000.tx.186: CHAPSO, 3-[(3-chol-amidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate; 

Phrase: "CHAPSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055270:chapso [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-chol-amidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-2-hydroxy-1-propanesulfonate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0138693:propanesulfonate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.187: DAPT, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester; 

Phrase: "DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "N-[N-(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: "5-difluorophenacetyl"

Phrase: ")-"

Phrase: "L-alanyl"

Phrase: "]-"

Phrase: "("

Phrase: "S)-"

Phrase: "phenylglycine t-butyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.188: ELISA, enzyme-linked immunosorbent assay. 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.189: 2 I. 

Phrase: "2 I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.190: Hayashi, Y. 

Phrase: "Hayashi,"

Phrase: "Y."
Processing 00000000.tx.191: Urano, R. 

Phrase: "Urano,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.192: Fukuda, N. 

Phrase: "Fukuda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.193: Isoo, T. 

Phrase: "Isoo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.194: Kodama, T. 

Phrase: "Kodama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.195: Hamakubo, T. 

Phrase: "Hamakubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.196: Tomita, and T. 

Phrase: "Tomita,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.197: Iwatsubo, unpublished data. 

Phrase: "Iwatsubo,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.198: 3 I. 

Phrase: "3 I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.199: Hayashi, Y. 

Phrase: "Hayashi,"

Phrase: "Y."
Processing 00000000.tx.200: Urano, R. 

Phrase: "Urano,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.201: Fukuda, N. 

Phrase: "Fukuda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.202: Isoo, T. 

Phrase: "Isoo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.203: Kodama, T. 

Phrase: "Kodama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.204: Hamakubo, T. 

Phrase: "Hamakubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.205: Tomita, and T. 

Phrase: "Tomita,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.206: Iwatsubo, unpublished observations. 

Phrase: "Iwatsubo,"

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.207: 4 T. 

Phrase: "4 T."
Processing 00000000.tx.208: Hamakubo, Y. 

Phrase: "Hamakubo,"

Phrase: "Y."
Processing 00000000.tx.209: Urano, R. 

Phrase: "Urano,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.210: Fukuda, and T. 

Phrase: "Fukuda,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.211: Kodama, unpublished result.  

Phrase: "Kodama,"

Phrase: "unpublished result."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]
Processing 00000000.tx.212: ACKNOWLEDGMENTS  We thank Takeda Chemical Industries for the kind offer of the A ELISAs, Gopal Thinakaran for the peptide immunogen for the PNT3 antibody, and N. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Takeda Chemical Industries for the kind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007983:Industries, Chemical [Organization]
   753   C0021267:Industries [Occupational Activity]

Phrase: "offer of the"

Phrase: "A ELISAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0014441:ELISA [Laboratory Procedure]

Phrase: "Gopal Thinakaran for the peptide immunogen"

Phrase: "for the PNT3 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.213: Takasugi, R. 

Phrase: "Takasugi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.214: Katayama, M. 

Phrase: "Katayama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.215: Tsuruoka, M. 

Phrase: "Tsuruoka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.216: Niimura, Y. 

Phrase: "Niimura,"

Phrase: "Y."
Processing 00000000.tx.217: Takahashi, N. 

Phrase: "Takahashi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.218: Watanabe, and Y. 

Phrase: "Watanabe,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.219: Morohashi for helpful discussions and technical assistance.  

Phrase: "Morohashi for helpful discussions"

Phrase: "and"

Phrase: "technical assistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018896:Assistance [Social Behavior]
   861   C0449851:Technical [Functional Concept]
Processing 00000000.tx.220: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Massotte, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Massotte,"

Phrase: "D."
Processing 00000000.tx.221: (2003) Biochim. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.222: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.223: Acta 1610, 77-89[Medline] [OrderarticleviaInfotrieve] Loisel, T. 

Phrase: "Acta 1610,"

Phrase: "77-89"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Loisel,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.224: P., Ansanay, H., St.-Onge, S., Gay, B., Boulanger, P., Strosberg, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ansanay,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "St.-Onge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337945:Onge [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Gay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019898:gay [Population Group]
  1000   C0019900:Gay [Social Behavior]
  1000   C0242657:Gay [Population Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Boulanger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Strosberg,"

Phrase: "A."
Processing 00000000.tx.225: D., Marullo, S., and Bouvier, M. 

Phrase: "D."

Phrase: ","

Phrase: "Marullo,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Bouvier,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.226: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.227: Biotech. 

Phrase: "Biotech."
Processing 00000000.tx.228: 15, 1300-1304[Medline] [OrderarticleviaInfotrieve] Masuda, K., Itoh, H., Sakihama, T., Akiyama, C., Takahashi, K., Fukuda, R., Yokomizo, T., Shimizu, T., Kodama, T., and Hamakubo, T. 

Phrase: "15,"

Phrase: "1300-1304"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Masuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Itoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sakihama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Akiyama,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukuda,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yokomizo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimizu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kodama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamakubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.229: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.230: Biol. 

Phrase: "Biol."
Processing 00000000.tx.231: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.232: 278, 24552-24562[Abstract/Free FullText] Urano, Y., Yamaguchi, M., Fukuda, R., Masuda, K., Takahashi, K., Uchiyama, Y., Iwanari, H., Jiang, S.Y., Naito, M., Kodama, T., and Hamakubo, T. 

Phrase: "278,"

Phrase: "24552-24562"

Phrase: "[Abstract/Free FullText"

Phrase: "] Urano,"

Phrase: "Y.,"

Phrase: "Yamaguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Fukuda,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uchiyama,"

Phrase: "Y.,"

Phrase: "Iwanari,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jiang,"

Phrase: "S."

Phrase: "Y.,"

Phrase: "Naito,"

Phrase: "M."

Phrase: ","

Phrase: "Kodama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamakubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.233: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.234: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.235: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.236: Commun. 

Phrase: "Commun."
Processing 00000000.tx.237: 308, 191-196[CrossRef][Medline] [OrderarticleviaInfotrieve] Wolfe, M. 

Phrase: "308,"

Phrase: "191-196"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.238: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.239: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.240: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.241: Drug Discov. 

Phrase: "Drug Discov."
Processing 00000000.tx.242: 1, 859-866[CrossRef][Medline] [OrderarticleviaInfotrieve] De Strooper, B. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "859-866"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.243: (2003) Neuron 38, 9-12[Medline] [OrderarticleviaInfotrieve] Haass, C., and Steiner, H. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "9-12"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.244: (2002) Trends Cell Biol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.245: 12, 556-562[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "12,"

Phrase: "556-562"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.246: J., and Kopan, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: (2003) Annu. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.248: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.249: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.250: 26, 565-597[CrossRef][Medline] [OrderarticleviaInfotrieve] Hu, Y., and Fortini, M. 

Phrase: "26,"

Phrase: "565-597"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hu,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Fortini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.251: E. 

Phrase: "E."
Processing 00000000.tx.252: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.253: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.254: 161, 685-690[Abstract/Free FullText] Kim, S. 

Phrase: "161,"

Phrase: "685-690"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.255: H., Ikeuchi, T., Yu, C., and Sisodia, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.257: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.258: Biol. 

Phrase: "Biol."
Processing 00000000.tx.259: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.260: 278, 33992-34002[Abstract/Free FullText] Kimberly, W. 

Phrase: "278,"

Phrase: "33992-34002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimberly,"

Phrase: "W."
Processing 00000000.tx.261: T., LaVoie, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "LaVoie,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: J., Ostaszewski, B. 

Phrase: "J.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.263: L., Ye, W., Wolfe, M. 

Phrase: "L., Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "W.,"

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.264: S., and Selkoe, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.265: J. 

Phrase: "J."
Processing 00000000.tx.266: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.267: Natl. 

Phrase: "Natl."
Processing 00000000.tx.268: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.269: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.270: U. 

Phrase: "U."
Processing 00000000.tx.271: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.272: A. 

Phrase: "A."
Processing 00000000.tx.273: 100, 6382-6387[Abstract/Free FullText] Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., and Iwatsubo, T. 

Phrase: "100,"

Phrase: "6382-6387"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hayashi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsuruoka,"

Phrase: "M."

Phrase: ","

Phrase: "Niimura,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.274: (2003) Nature 422, 438-441[CrossRef][Medline] [OrderarticleviaInfotrieve] Edbauer, D., Winkler, E., Regula, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 422,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "438-441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Regula,"

Phrase: "J."
Processing 00000000.tx.275: T., Pesold, B., Steiner, H., and Haass, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.276: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.277: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.278: 5, 486-488[CrossRef][Medline] [OrderarticleviaInfotrieve] Thinakaran, G., Harris, C. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "486-488"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Harris,"

Phrase: "C."
Processing 00000000.tx.279: L., Ratovitski, T., Davenport, F., Slunt, H. 

Phrase: "L., Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.280: H., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.281: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.282: R., and Sisodia, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.283: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.284: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.285: Biol. 

Phrase: "Biol."
Processing 00000000.tx.286: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.287: 272, 28415-28422[Abstract/Free FullText] Tomita, T., Maruyama, K., Saido, T. 

Phrase: "272,"

Phrase: "28415-28422"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.288: C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grunberg, J., Haass, C., Iwatsubo, T., and Obata, K. 

Phrase: "C., Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.289: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.290: Natl. 

Phrase: "Natl."
Processing 00000000.tx.291: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.292: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.293: U. 

Phrase: "U."
Processing 00000000.tx.294: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.295: A. 

Phrase: "A."
Processing 00000000.tx.296: 94, 2025-2030[Abstract/Free FullText] Tomita, T., Katayama, R., Takikawa, R., and Iwatsubo, T. 

Phrase: "94,"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Katayama,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Takikawa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: (2002) FEBS Lett. 

Phrase: "(2002"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.298: 520, 117-121[CrossRef][Medline] [OrderarticleviaInfotrieve] Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T., and Iwatsubo, T. 

Phrase: "520,"

Phrase: "117-121"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takahashi,"

Phrase: "Y.,"

Phrase: "Hayashi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tominari,"

Phrase: "Y.,"

Phrase: "Rikimaru,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Morohashi,"

Phrase: "Y.,"

Phrase: "Kan,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Natsugari,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fukuyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.299: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.300: Biol. 

Phrase: "Biol."
Processing 00000000.tx.301: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.302: 278, 18664-18670[Abstract/Free FullText] Kan, T., Tominari, Y., Morohashi, Y., Natsugari, H., Tomita, T., Iwatsubo, T., and Fukuyama, T. 

Phrase: "278,"

Phrase: "18664-18670"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kan,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tominari,"

Phrase: "Y.,"

Phrase: "Morohashi,"

Phrase: "Y.,"

Phrase: "Natsugari,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Fukuyama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.303: (2003) Chem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.304: Commun. 

Phrase: "Commun."
Processing 00000000.tx.305: 7, 2244-2245[CrossRef] Tomita, T., Watabiki, T., Takikawa, R., Morohashi, Y., Takasugi, N., Kopan, R., De Strooper, B., and Iwatsubo, T. 

Phrase: "7,"

Phrase: "2244-2245"

Phrase: "[CrossRef"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Watabiki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takikawa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Morohashi,"

Phrase: "Y.,"

Phrase: "Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kopan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.306: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.307: Biol. 

Phrase: "Biol."
Processing 00000000.tx.308: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.309: 276, 33273-33281[Abstract/Free FullText] Tomita, T., Takikawa, R., Koyama, A., Morohashi, Y., Takasugi, N., Saido, T. 

Phrase: "276,"

Phrase: "33273-33281"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takikawa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koyama,"

Phrase: "A.,"

Phrase: "Morohashi,"

Phrase: "Y.,"

Phrase: "Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.310: C., Maruyama, K., and Iwatsubo, T. 

Phrase: "C., Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.311: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.312: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.313: 19, 10627-10634[Abstract/Free FullText] Tomita, T., Tokuhiro, S., Hashimoto, T., Aiba, K., Saido, T. 

Phrase: "19,"

Phrase: "10627-10634"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Hashimoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aiba,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.314: C., Maruyama, K., and Iwatsubo, T. 

Phrase: "C., Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.315: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.316: Biol. 

Phrase: "Biol."
Processing 00000000.tx.317: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.318: 273, 21153-21160[Abstract/Free FullText] Morohashi, Y., Hatano, N., Ohya, S., Takikawa, R., Watabiki, T., Takasugi, N., Imaizumi, Y., Tomita, T., and Iwatsubo, T. 

Phrase: "273,"

Phrase: "21153-21160"

Phrase: "[Abstract/Free FullText"

Phrase: "] Morohashi,"

Phrase: "Y.,"

Phrase: "Hatano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ohya,"

Phrase: "S."

Phrase: ","

Phrase: "Takikawa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watabiki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Imaizumi,"

Phrase: "Y.,"

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.319: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.320: Biol. 

Phrase: "Biol."
Processing 00000000.tx.321: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.322: 277, 14965-14975[Abstract/Free FullText] Takasugi, N., Takahashi, Y., Morohashi, Y., Tomita, T., and Iwatsubo, T. 

Phrase: "277,"

Phrase: "14965-14975"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Morohashi,"

Phrase: "Y.,"

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.323: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.324: Biol. 

Phrase: "Biol."
Processing 00000000.tx.325: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.326: 277, 50198-50205[Abstract/Free FullText] Octave, J. 

Phrase: "277,"

Phrase: "50198-50205"

Phrase: "[Abstract/Free FullText"

Phrase: "] Octave,"

Phrase: "J."
Processing 00000000.tx.327: N., Essalmani, R., Tasiaux, B., Menager, J., Czech, C., and Mercken, L. 

Phrase: "N., Essalmani,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tasiaux,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Menager,"

Phrase: "J.,"

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Mercken,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.328: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.329: Biol. 

Phrase: "Biol."
Processing 00000000.tx.330: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.331: 275, 1525-1528[Abstract/Free FullText] Pitsi, D., Kienlen-Campard, P., and Octave, J. 

Phrase: "275,"

Phrase: "1525-1528"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pitsi,"

Phrase: "D."

Phrase: ","

Phrase: "Kienlen-Campard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.332: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.333: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.335: 83, 390-399[CrossRef][Medline] [OrderarticleviaInfotrieve] Li, Y. 

Phrase: "83,"

Phrase: "390-399"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y."
Processing 00000000.tx.336: M., Lai, M. 

Phrase: "M."

Phrase: ","

Phrase: "Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.337: T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xu,"

Phrase: "M."

Phrase: ","

Phrase: "Huang,"

Phrase: "Q.,"

Phrase: "DiMuzio-Mower,"

Phrase: "J.,"

Phrase: "Sardana,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: K., Shi, X. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shi,"

Phrase: "X."
Processing 00000000.tx.339: P., Yin, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.340: C., Shafer, J. 

Phrase: "C., Shafer,"

Phrase: "J."
Processing 00000000.tx.341: A., and Gardell, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Gardell,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.342: J. 

Phrase: "J."
Processing 00000000.tx.343: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.344: Natl. 

Phrase: "Natl."
Processing 00000000.tx.345: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.346: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.347: U. 

Phrase: "U."
Processing 00000000.tx.348: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: A. 

Phrase: "A."
Processing 00000000.tx.350: 97, 6138-6143[Abstract/Free FullText] Kimberly, W. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "6138-6143"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimberly,"

Phrase: "W."
Processing 00000000.tx.351: T., Esler, W. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Esler,"

Phrase: "W."
Processing 00000000.tx.352: P., Ye, W., Ostaszewski, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "W.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.353: L., Gao, J., Diehl, T., Selkoe, D. 

Phrase: "L., Gao,"

Phrase: "J.,"

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.354: J., and Wolfe, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.356: (2003) Biochemistry 42, 137-144[CrossRef][Medline] [OrderarticleviaInfotrieve] Wolfe, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "137-144"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: S., Xia, W., Ostaszewski, B. 

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.358: L., Diehl, T. 

Phrase: "L., Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.359: S., Kimberly, W. 

Phrase: "S."

Phrase: ","

Phrase: "Kimberly,"

Phrase: "W."
Processing 00000000.tx.360: T., and Selkoe, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.361: J. 

Phrase: "J."
Processing 00000000.tx.362: (1999) Nature 398, 513-517[CrossRef][Medline] [OrderarticleviaInfotrieve] Beher, D., Fricker, M., Nadin, A., Clarke, E. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "513-517"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Beher,"

Phrase: "D."

Phrase: ","

Phrase: "Fricker,"

Phrase: "M."

Phrase: ","

Phrase: "Nadin,"

Phrase: "A.,"

Phrase: "Clarke,"

Phrase: "E."
Processing 00000000.tx.363: E., Wrigley, J. 

Phrase: "E.,"

Phrase: "Wrigley,"

Phrase: "J."
Processing 00000000.tx.364: D., Li, Y. 

Phrase: "D."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y."
Processing 00000000.tx.365: M., Culvenor, J. 

Phrase: "M."

Phrase: ","

Phrase: "Culvenor,"

Phrase: "J."
Processing 00000000.tx.366: G., Masters, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.367: L., Harrison, T., and Shearman, M. 

Phrase: "L., Harrison,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shearman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.369: (2003) Biochemistry 42, 8133-8142[CrossRef][Medline] [OrderarticleviaInfotrieve] Lai, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8133-8142"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: T., Chen, E., Crouthamel, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "E.,"

Phrase: "Crouthamel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: C., DiMuzio-Mower, J., Xu, M., Huang, Q., Price, E., Register, R. 

Phrase: "C., DiMuzio-Mower,"

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "M."

Phrase: ","

Phrase: "Huang,"

Phrase: "Q.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "E.,"

Phrase: "Register,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.372: B., Shi, X. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shi,"

Phrase: "X."
Processing 00000000.tx.373: P., Donoviel, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Donoviel,"

Phrase: "D."
Processing 00000000.tx.374: B., Bernstein, A., Hazuda, D., Gardell, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bernstein,"

Phrase: "A.,"

Phrase: "Hazuda,"

Phrase: "D."

Phrase: ","

Phrase: "Gardell,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: J., and Li, Y. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y."
Processing 00000000.tx.376: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.377: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.378: Biol. 

Phrase: "Biol."
Processing 00000000.tx.379: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.380: 278, 22475-22481[Abstract/Free FullText] Iwatsubo, T. 

Phrase: "278,"

Phrase: "22475-22481"

Phrase: "[Abstract/Free FullText"

Phrase: "] Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.381: (2004) Mol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.382: Psychiatry 9, 8-10[CrossRef][Medline] [OrderarticleviaInfotrieve] Xia, W., Zhang, J., Ostaszewski, B.L., Kimberly, W. 

Phrase: "Psychiatry 9,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "8-10"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Ostaszewski,"

Phrase: "B.L., Kimberly,"

Phrase: "W."
Processing 00000000.tx.383: T., Seubert, P., Koo, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.384: H., Shen, J., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shen,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.385: J. 

Phrase: "J."
Processing 00000000.tx.386: (1998) Biochemistry 37, 16465-16471[CrossRef][Medline] [OrderarticleviaInfotrieve] Iwata, H., Tomita, T., Maruyama, K., and Iwatsubo, T. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "16465-16471"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.387: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Biol. 

Phrase: "Biol."
Processing 00000000.tx.389: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.390: 276, 21678-21685[Abstract/Free FullText] Kaether, C., Lammich, S., Edbauer, D., Ertl, M., Rietdorf, J., Capell, A., Steiner, H., and Haass, C. 

Phrase: "276,"

Phrase: "21678-21685"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaether,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Ertl,"

Phrase: "M."

Phrase: ","

Phrase: "Rietdorf,"

Phrase: "J.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.391: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.392: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.393: 158, 551-561[Abstract/Free FullText] Braunagel, S. 

Phrase: "158,"

Phrase: "551-561"

Phrase: "[Abstract/Free FullText"

Phrase: "] Braunagel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.394: C., and Summers, M. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Summers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0241301:Summer [Temporal Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.395: D. 

Phrase: "D."
Processing 00000000.tx.396: (1994) Virology 202, 315-328[CrossRef][Medline] [OrderarticleviaInfotrieve] Yeh, L. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Virology 202,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042762:Virology [Biomedical Occupation or Discipline]
   861   C0205466:virology [Functional Concept]

Phrase: "315-328"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yeh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.397: H., Bajpai, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bajpai,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: K., and Sun, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.399: Y. 

Phrase: "Y."
Processing 00000000.tx.400: (1997) Lipids 32, 481-487[Medline] [OrderarticleviaInfotrieve] Marheineke, K., Grunewald, S., Christie, W., and Reilander, H. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Lipids 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "481-487"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marheineke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Grunewald,"

Phrase: "S."

Phrase: ","

Phrase: "Christie,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Reilander,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.401: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.402: 441, 49-52[CrossRef][Medline] [OrderarticleviaInfotrieve] Zhang, S. 

Phrase: "441,"

Phrase: "49-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.403: X., Han, Y., and Blissard, G. 

Phrase: "X.,"

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Blissard,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.405: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.406: 77, 6265-6273[Abstract/Free FullText] Manes, S., del Real, G., and Martinez-A, C. 

Phrase: "77,"

Phrase: "6265-6273"

Phrase: "[Abstract/Free FullText"

Phrase: "] Manes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0222048:manes [Body Part, Organ, or Organ Component]
   966 E C0332170:mane [Temporal Concept]

Phrase: "S."

Phrase: ","

Phrase: "del Real, G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Martinez-"

Phrase: "A,"

Phrase: "C."
Processing 00000000.tx.407: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.408: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.409: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.410: 3, 557-568[CrossRef][Medline] [OrderarticleviaInfotrieve] Braunagel, S. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "557-568"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Braunagel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.411: C., Russell, W. 

Phrase: "C., Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979971:Russell [Laboratory Procedure]

Phrase: "W."
Processing 00000000.tx.412: K., Rosas-Acosta, G., Russell, D., and Summers, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rosas-Acosta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Summers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0241301:Summer [Temporal Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: D. 

Phrase: "D."
Processing 00000000.tx.414: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.415: Natl. 

Phrase: "Natl."
Processing 00000000.tx.416: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.417: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.418: U. 

Phrase: "U."
Processing 00000000.tx.419: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: A. 

Phrase: "A."
Processing 00000000.tx.421: 100, 9797-9802[Abstract/Free FullText]

Phrase: "100,"

Phrase: "9797-9802"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

